Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.
Infections with bacteria of the genus KLEBSIELLA.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
Short filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man.
Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.
A species of gram-negative bacteria causing URINARY TRACT INFECTIONS and SEPTICEMIA.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
Substances that reduce the growth or reproduction of BACTERIA.
A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain.
Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.
A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock.
Proteins found in any species of bacterium.
An enzyme system that catalyzes the fixing of nitrogen in soil bacteria and blue-green algae (CYANOBACTERIA). EC 1.18.6.1.
Solitary or multiple collections of PUS within the liver as a result of infection by bacteria, protozoa, or other agents.
The process in certain BACTERIA; FUNGI; and CYANOBACTERIA converting free atmospheric NITROGEN to biologically usable forms of nitrogen, such as AMMONIA; NITRATES; and amino compounds.
The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.
Deoxyribonucleic acid that makes up the genetic material of bacteria.
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
Infections with bacteria of the family ENTEROBACTERIACEAE.
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
The functional hereditary units of BACTERIA.
A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
Any infection which a patient contracts in a health-care institution.
Interstitial pneumonia caused by extensive infection of the lungs (LUNG) and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR.
Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method.
Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.
Inflammation of the lung parenchyma that is caused by bacterial infections.
Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
Single or multiple areas of PUS due to bacterial infection within the hepatic parenchyma. It can be caused by a variety of BACTERIA, local or disseminated from infections elsewhere such as in APPENDICITIS; CHOLECYSTITIS; PERITONITIS; and after LIVER TRANSPLANTATION.
An envelope of loose gel surrounding a bacterial cell which is associated with the virulence of pathogenic bacteria. Some capsules have a well-defined border, whereas others form a slime layer that trails off into the medium. Most capsules consist of relatively simple polysaccharides but there are some bacteria whose capsules are made of polypeptides.
A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE, which is active in nitrogen fixation, and consists of two subunits with molecular weights of 59.5 kDa and 50.7 kDa, respectively.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Gel electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length.
A parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate EUKARYOTA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.
Infections with bacteria of the genus CHLAMYDOPHILA.
The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors.
Semisynthetic broad-spectrum cephalosporin.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Acetylene is not typically considered a medical term, but rather a chemical compound (C2H2) commonly used in industrial and laboratory settings for its high energy content and reactivity, which may have various applications in medicine such as wound healing and surgical procedures, but it is not a medical diagnosis or disease.
Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.
Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
Non-susceptibility of an organism to the action of the cephalosporins.
Institutions with an organized medical staff which provide medical care to patients.
Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.
Polysaccharides found in bacteria and in capsules thereof.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in water, sewage, soil, meat, hospital environments, and on the skin and in the intestinal tract of man and animals as a commensal.
Direct nucleotide sequencing of gene fragments from multiple housekeeping genes for the purpose of phylogenetic analysis, organism identification, and typing of species, strain, serovar, or other distinguishable phylogenetic level.
A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.
A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.
Infections with bacteria of the species ESCHERICHIA COLI.
A semisynthetic cephamycin antibiotic resistant to beta-lactamase.
Gram-negative, capsulated, gas-producing rods found widely in nature. Both motile and non-motile strains exist. The species is closely related to KLEBSIELLA PNEUMONIAE and is frequently associated with nosocomial infections
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract.
Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
Infections by bacteria, general or unspecified.
Process of determining and distinguishing species of bacteria or viruses based on antigens they share.
A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.
A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.
A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed)
Bacteria which retain the crystal violet stain when treated by Gram's method.
One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.
Using MOLECULAR BIOLOGY techniques, such as DNA SEQUENCE ANALYSIS; PULSED-FIELD GEL ELECTROPHORESIS; and DNA FINGERPRINTING, to identify, classify, and compare organisms and their subtypes.
A broad-spectrum antimicrobial carboxyfluoroquinoline.
Nonsusceptibility of an organism to the action of penicillins.
Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.
Immunoglobulins produced in a response to BACTERIAL ANTIGENS.
Porins are protein molecules that were originally found in the outer membrane of GRAM-NEGATIVE BACTERIA and that form multi-meric channels for the passive DIFFUSION of WATER; IONS; or other small molecules. Porins are present in bacterial CELL WALLS, as well as in plant, fungal, mammalian and other vertebrate CELL MEMBRANES and MITOCHONDRIAL MEMBRANES.
I'm sorry for any confusion, but "Greece" is a country in southeastern Europe and not a medical term or condition. If you have any medical questions or need a definition related to medicine, I would be happy to help.
Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.
A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria.
Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
A genus of gram-negative, aerobic bacteria found in soil and water. Its organisms occur singly, in pairs or irregular clumps, and sometimes in chains of varying lengths.
Techniques used in studying bacteria.
Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.
A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
In bacteria, a group of metabolically related genes, with a common promoter, whose transcription into a single polycistronic MESSENGER RNA is under the control of an OPERATOR REGION.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples.
Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping.
A method where a culturing surface inoculated with microbe is exposed to small disks containing known amounts of a chemical agent resulting in a zone of inhibition (usually in millimeters) of growth of the microbe corresponding to the susceptibility of the strain to the agent.
Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
Clavulanic acid and its salts and esters. The acid is a suicide inhibitor of bacterial beta-lactamase enzymes from Streptomyces clavuligerus. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase.
The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
A technique for identifying individuals of a species that is based on the uniqueness of their DNA sequence. Uniqueness is determined by identifying which combination of allelic variations occur in the individual at a statistically relevant number of different loci. In forensic studies, RESTRICTION FRAGMENT LENGTH POLYMORPHISM of multiple, highly polymorphic VNTR LOCI or MICROSATELLITE REPEAT loci are analyzed. The number of loci used for the profile depends on the ALLELE FREQUENCY in the population.
The lipopolysaccharide-protein somatic antigens, usually from gram-negative bacteria, important in the serological classification of enteric bacilli. The O-specific chains determine the specificity of the O antigens of a given serotype. O antigens are the immunodominant part of the lipopolysaccharide molecule in the intact bacterial cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
An enzyme that catalyzes the dehydration of 1,2-propanediol to propionaldehyde. EC 4.2.1.28.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.
Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.
Thin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein (pilin) in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins (ADHESINS, BACTERIAL). Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of "pili", which is confined to sex pili (PILI, SEX).
The heritable modification of the properties of a competent bacterium by naked DNA from another source. The uptake of naked DNA is a naturally occuring phenomenon in some bacteria. It is often used as a GENE TRANSFER TECHNIQUE.
The top portion of the pharynx situated posterior to the nose and superior to the SOFT PALATE. The nasopharynx is the posterior extension of the nasal cavities and has a respiratory function.
Proteins isolated from the outer membrane of Gram-negative bacteria.
A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.94. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase. (From Dorland, 27th ed)
A granulomatous disease caused by KLEBSIELLA RHINOSCLEROMATIS infection. Despite its name, this disease is not limited to the nose and NASOPHARYNX but may affect any part of the RESPIRATORY TRACT, sometimes with extension to the lip and the skin.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in humans and other animals including MAMMALS; BIRDS; REPTILES; and AMPHIBIANS. It has also been isolated from SOIL and WATER as well as from clinical specimens such as URINE; THROAT; SPUTUM; BLOOD; and wound swabs as an opportunistic pathogen.
Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity.
I'm sorry for any confusion, but "Taiwan" is not a medical term and does not have a medical definition. It is a country located in East Asia. If you have any questions related to healthcare or medical terms, I would be happy to help with those!
Thioglycosides are organic compounds consisting of a glycosyl group linked to a sulfur atom, often used in medicinal chemistry as antimicrobial, antiviral, and antifungal agents, or as enzyme inhibitors.
Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
Infections with bacteria of the genus CHLAMYDIA.
The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.
A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
Discrete segments of DNA which can excise and reintegrate to another site in the genome. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA transposable elements include bacterial IS (insertion sequence) elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the human Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom.
Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.
Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species.
DNA elements that include the component genes and insertion site for a site-specific recombination system that enables them to capture mobile gene cassettes.
Hospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research.
Bacterial infections of the leptomeninges and subarachnoid space, frequently involving the cerebral cortex, cranial nerves, cerebral blood vessels, spinal cord, and nerve roots.
Cephalosporinase is an enzyme produced by certain bacteria that can hydrolyze and confer resistance to cephalosporin antibiotics.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
The complete absence, or (loosely) the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
4-carbon straight chain aliphatic hydrocarbons substituted with two hydroxyl groups. The hydroxyl groups cannot be on the same carbon atom.
Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.
The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST.
A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
Encrustations, formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedding in extracellular polymers, that adhere to surfaces such as teeth (DENTAL DEPOSITS); PROSTHESES AND IMPLANTS; and catheters. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and antifouling agents.
Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.
Exotoxins produced by certain strains of streptococci, particularly those of group A (STREPTOCOCCUS PYOGENES), that cause HEMOLYSIS.
Naphthyridines are a class of heterocyclic organic compounds containing a naphthyridine nucleus, which is a polycyclic aromatic hydrocarbon made up of two benzene rings fused to a pyridine ring, and they have been studied for their potential pharmacological properties, including as antimicrobial, antiviral, and anticancer agents.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the natural environment (soil, water, and plant surfaces) or as an opportunistic human pathogen.
A sugar alcohol formed by the reduction of ribose.
Substances elaborated by bacteria that have antigenic activity.
An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)
Viruses whose hosts are bacterial cells.
A family of signal transducing adaptor proteins that control the METABOLISM of NITROGEN. They are primarily found in prokaryotes.
The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
A mixture of polymyxins B1 and B2, obtained from Bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic.

Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene. (1/3057)

A clinical isolate, Escherichia coli MG-1, isolated from a 4-month-old Vietnamese orphan child, produced a beta-lactamase conferring resistance to extended-spectrum cephalosporins and aztreonam. In a disk diffusion test, a typical synergistic effect between ceftazidime or aztreonam and clavulanic acid was observed along with an unusual synergy between cefoxitin and cefuroxime. The gene for VEB-1 (Vietnamese extended-spectrum beta-lactamase) was cloned and expressed in E. coli JM109. The recombinant plasmid pRLT1 produced a beta-lactamase with a pI of 5.35 and conferred high-level resistance to extended-spectrum (or oxyimino) cephalosporins and to aztreonam. Vmax values for extended-spectrum cephalosporins were uncommonly high, while the affinity of the enzyme for ceftazidime and aztreonam was relatively low. blaVEB-1 showed significant homology at the DNA level with only blaPER-1 and blaPER-2. Analysis of the deduced protein sequence showed that VEB-1 is a class A penicillinase having very low levels of homology with any other known beta-lactamases. The highest percentage of amino acid identity was 38% with PER-1 or PER-2, two uncommon class A extended-spectrum enzymes. Exploration of the genetic environment of blaVEB-1 revealed the presence of gene cassette features, i.e., (i) a 59-base element associated with blaVEB-1; (ii) a second 59-base element just upstream of blaVEB-1, likely belonging to the aacA1-orfG gene cassette; (iii) two core sites (GTTRRRY) on both sides of blaVEB-1; and (iv) a second antibiotic resistance gene 3' of blaVEB-1, aadB. blaVEB-1 may therefore be the first class A extended-spectrum beta-lactamase that is part of a gene cassette, which itself is likely to be located on a class 1 integron, as sulfamide resistance may indicate. Furthermore, blaVEB-1 is encoded on a large (> 100-kb) transferable plasmid found in a Klebsiella pneumoniae MG-2 isolated at the same time from the same patient, indicating a horizontal gene transfer.  (+info)

Metabolic engineering of a 1,2-propanediol pathway in Escherichia coli. (2/3057)

1,2-Propanediol (1,2-PD) is a major commodity chemical that is currently derived from propylene, a nonrenewable resource. A goal of our research is to develop fermentation routes to 1,2-PD from renewable resources. Here we report the production of enantiomerically pure R-1,2-PD from glucose in Escherichia coli expressing NADH-linked glycerol dehydrogenase genes (E. coli gldA or Klebsiella pneumoniae dhaD). We also show that E. coli overexpressing the E. coli methylglyoxal synthase gene (mgs) produced 1,2-PD. The expression of either glycerol dehydrogenase or methylglyoxal synthase resulted in the anaerobic production of approximately 0.25 g of 1,2-PD per liter. R-1,2-PD production was further improved to 0.7 g of 1,2-PD per liter when methylglyoxal synthase and glycerol dehydrogenase (gldA) were coexpressed. In vitro studies indicated that the route to R-1,2-PD involved the reduction of methylglyoxal to R-lactaldehyde by the recombinant glycerol dehydrogenase and the reduction of R-lactaldehyde to R-1, 2-PD by a native E. coli activity. We expect that R-1,2-PD production can be significantly improved through further metabolic and bioprocess engineering.  (+info)

In-vitro selection of porin-deficient mutants of two strains of Klebsiella pneumoniae with reduced susceptibilities to meropenem, but not to imipenem. (3/3057)

We have evaluated the ability of imipenem and meropenem to select, in vitro, resistant mutants of two clinical isolates of Klebsiella pneumoniae producing both SHV and TEM beta-lactamases. Only meropenem selected mutants of both isolates for which the MICs of meropenem, but not imipenem, were markedly higher than those for the parent strains; the MICs of several other beta-lactam antibiotics, including beta-lactam/beta-lactamase inhibitor combinations, for these mutants were also higher than those for the parent strains. In contrast, the MICs for the imipenem-selected mutants were the same as, or similar to, those for the parent strains. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis analysis revealed that an outer membrane protein in both parent strains was absent in the meropenem-selected mutants, but not in the imipenem-selected mutants. This protein is likely to be a porin, the absence of which is presumably associated with impaired beta-lactam permeability and, therefore, the reduced susceptibilities to these antibiotics exhibited by the mutant strains. We believe that this is the first report of the in-vitro selection of porin-deficient mutants of K. pneumoniae following exposure to meropenem.  (+info)

Phagocytosis of Vibrio cholerae O139 Bengal by human polymorphonuclear leukocytes. (4/3057)

Capsulated bacteria exhibit serum (complement) resistance and resistance to phagocytosis, which result in disseminated infections. Vibrio cholerae O139 strains possess a thin capsule and have been found to be partially serum resistant in a previous study. In the present study, compared to a standard capsulated Klebsiella pneumoniae strain, which showed total resistance to killing by phagocytosis, V. cholerae O139 strains were shown to be only partially resistant, with most strains showing <40% survival. These findings may explain the relative rarity of V. cholerae O139 bacteremia in cholera caused by this organism.  (+info)

Tyrosine aminotransferase catalyzes the final step of methionine recycling in Klebsiella pneumoniae. (5/3057)

An aminotransferase which catalyzes the final step in methionine recycling from methylthioadenosine, the conversion of alpha-ketomethiobutyrate to methionine, has been purified from Klebsiella pneumoniae and characterized. The enzyme was found to be a homodimer of 45-kDa subunits, and it catalyzed methionine formation primarily using aromatic amino acids and glutamate as the amino donors. Histidine, leucine, asparagine, and arginine were also functional amino donors but to a lesser extent. The N-terminal amino acid sequence of the enzyme was determined and found to be almost identical to the N-terminal sequence of both the Escherichia coli and Salmonella typhimurium tyrosine aminotransferases (tyrB gene products). The structural gene for the tyrosine aminotransferase was cloned from K. pneumoniae and expressed in E. coli. The deduced amino acid sequence displayed 83, 80, 38, and 34% identity to the tyrosine aminotransferases from E. coli, S. typhimurium, Paracoccus denitrificans, and Rhizobium meliloti, respectively, but it showed less than 13% identity to any characterized eukaryotic tyrosine aminotransferase. Structural motifs around key invariant residues placed the K. pneumoniae enzyme within the Ia subfamily of aminotransferases. Kinetic analysis of the aminotransferase showed that reactions of an aromatic amino acid with alpha-ketomethiobutyrate and of glutamate with alpha-ketomethiobutyrate proceed as favorably as the well-known reactions of tyrosine with alpha-ketoglutarate and tyrosine with oxaloacetate normally associated with tyrosine aminotransferases. The aminotransferase was inhibited by the aminooxy compounds canaline and carboxymethoxylamine but not by substrate analogues, such as nitrotyrosine or nitrophenylalanine.  (+info)

Construction and characterization of mutations within the Klebsiella mrkD1P gene that affect binding to collagen type V. (6/3057)

The fimbria-associated MrkD1P protein mediates adherence of type 3 fimbriate strains of Klebsiella pneumoniae to collagen type V. Currently, three different MrkD adhesins have been described in Klebsiella species, and each possesses a distinctive binding pattern. Therefore, the binding abilities of mutants possessing defined mutations within the mrkD1P gene were examined in order to determine whether specific regions of the adhesin molecule were responsible for collagen binding. Both site-directed and chemically induced mutations were constructed within mrkD1P, and the ability of the gene products to be incorporated into fimbrial appendages or bind to collagen was determined. Binding to type V collagen was not associated solely with one particular region of the MrkD1P protein, and two classes of nonadhesive mutants were isolated. In one class of mutants, the MrkD adhesin was not assembled into the fimbrial shaft, whereas in the second class of mutants, the adhesin was associated with fimbriae but did not bind to collagen. Both hemagglutinating and collagen-binding activities were associated with the MrkD1P molecule, since P pili and type 3 fimbriae carrying adhesive MrkD proteins exhibited identical binding properties.  (+info)

Characterization of mdcR, a regulatory gene of the malonate catabolic system in Klebsiella pneumoniae. (7/3057)

The Klebsiella pneumoniae mdcR gene, which encodes a LysR-type regulator, was overexpressed in Escherichia coli. Purified MdcR was found to bind specifically to the control region of either the malonate decarboxylase (mdc) genes or mdcR. We have also demonstrated that MdcR is an activator of the expression of the mdc genes, whereas it represses the transcription of the putative control region of mdcR, PmdcR, indicating a negative autoregulatory control.  (+info)

Conserved organization in the cps gene clusters for expression of Escherichia coli group 1 K antigens: relationship to the colanic acid biosynthesis locus and the cps genes from Klebsiella pneumoniae. (8/3057)

Group 1 capsules of Escherichia coli are similar to the capsules produced by strains of Klebsiella spp. in terms of structure, genetics, and patterns of expression. The striking similarities between the capsules of these organisms prompted a more detailed investigation of the cps loci encoding group 1 capsule synthesis. Six strains of K. pneumoniae and 12 strains of E. coli were examined. PCR analysis showed that the clusters in these strains are conserved in their chromosomal locations. A highly conserved block of four genes, orfX-wza-wzb-wzc, was identified in all of the strains. The wza and wzc genes are required for translocation and surface assembly of E. coli K30 antigen. The conservation of these genes points to a common pathway for capsule translocation. A characteristic JUMPstart sequence was identified upstream of each cluster which may function in conjunction with RfaH to inhibit transcriptional termination at a stem-loop structure found immediately downstream of the "translocation-surface assembly" region of the cluster. Interestingly, the sequence upstream of the cps clusters in five E. coli strains and one Klebsiella strain indicated the presence of IS elements. We propose that the IS elements were responsible for the transfer of the cps locus between organisms and that they may continue to mediate recombination between strains.  (+info)

"Klebsiella pneumoniae" is a medical term that refers to a type of bacteria belonging to the family Enterobacteriaceae. It's a gram-negative, encapsulated, non-motile, rod-shaped bacterium that can be found in various environments, including soil, water, and the gastrointestinal tracts of humans and animals.

"Klebsiella pneumoniae" is an opportunistic pathogen that can cause a range of infections, particularly in individuals with weakened immune systems or underlying medical conditions. It's a common cause of healthcare-associated infections, such as pneumonia, urinary tract infections, bloodstream infections, and wound infections.

The bacterium is known for its ability to produce a polysaccharide capsule that makes it resistant to phagocytosis by white blood cells, allowing it to evade the host's immune system. Additionally, "Klebsiella pneumoniae" has developed resistance to many antibiotics, making infections caused by this bacterium difficult to treat and a growing public health concern.

Klebsiella infections are caused by bacteria called Klebsiella spp., with the most common species being Klebsiella pneumoniae. These gram-negative, encapsulated bacilli are normal inhabitants of the human gastrointestinal tract and upper respiratory tract but can cause various types of infections when they spread to other body sites.

Commonly, Klebsiella infections include:

1. Pneumonia: This is a lung infection that can lead to symptoms like cough, chest pain, difficulty breathing, and fever. It often affects people with weakened immune systems, chronic lung diseases, or those who are hospitalized.

2. Urinary tract infections (UTIs): Klebsiella can cause UTIs, particularly in individuals with compromised urinary tracts, such as catheterized patients or those with structural abnormalities. Symptoms may include pain, burning during urination, frequent urges to urinate, and lower abdominal or back pain.

3. Bloodstream infections (bacteremia/septicemia): When Klebsiella enters the bloodstream, it can cause bacteremia or septicemia, which can lead to sepsis, a life-threatening condition characterized by an overwhelming immune response to infection. Symptoms may include fever, chills, rapid heart rate, and rapid breathing.

4. Wound infections: Klebsiella can infect wounds, particularly in patients with open surgical wounds or traumatic injuries. Infected wounds may display redness, swelling, pain, pus discharge, and warmth.

5. Soft tissue infections: These include infections of the skin and underlying soft tissues, such as cellulitis and abscesses. Symptoms can range from localized redness, swelling, and pain to systemic symptoms like fever and malaise.

Klebsiella infections are increasingly becoming difficult to treat due to their resistance to multiple antibiotics, including carbapenems, which has led to the term "carbapenem-resistant Enterobacteriaceae" (CRE) or "carbapenem-resistant Klebsiella pneumoniae" (CRKP). These infections often require the use of last-resort antibiotics like colistin and tigecycline. Infection prevention measures, such as contact precautions, hand hygiene, and environmental cleaning, are crucial to controlling the spread of Klebsiella in healthcare settings.

Streptococcus pneumoniae, also known as the pneumococcus, is a gram-positive, alpha-hemolytic bacterium frequently found in the upper respiratory tract of healthy individuals. It is a leading cause of community-acquired pneumonia and can also cause other infectious diseases such as otitis media (ear infection), sinusitis, meningitis, and bacteremia (bloodstream infection). The bacteria are encapsulated, and there are over 90 serotypes based on variations in the capsular polysaccharide. Some serotypes are more virulent or invasive than others, and the polysaccharide composition is crucial for vaccine development. S. pneumoniae infection can be treated with antibiotics, but the emergence of drug-resistant strains has become a significant global health concern.

"Mycoplasma pneumoniae" is a type of bacteria that lacks a cell wall and can cause respiratory infections, particularly bronchitis and atypical pneumonia. It is one of the most common causes of community-acquired pneumonia. Infection with "M. pneumoniae" typically results in mild symptoms, such as cough, fever, and fatigue, although more severe complications can occur in some cases. The bacteria can also cause various extrapulmonary manifestations, including skin rashes, joint pain, and neurological symptoms. Diagnosis of "M. pneumoniae" infection is typically made through serological tests or PCR assays. Treatment usually involves antibiotics such as macrolides or tetracyclines.

Beta-lactamases are enzymes produced by certain bacteria that can break down and inactivate beta-lactam antibiotics, such as penicillins, cephalosporins, and carbapenems. This enzymatic activity makes the bacteria resistant to these antibiotics, limiting their effectiveness in treating infections caused by these organisms.

Beta-lactamases work by hydrolyzing the beta-lactam ring, a structural component of these antibiotics that is essential for their antimicrobial activity. By breaking down this ring, the enzyme renders the antibiotic ineffective against the bacterium, allowing it to continue growing and potentially causing harm.

There are different classes of beta-lactamases (e.g., Ambler Class A, B, C, and D), each with distinct characteristics and mechanisms for breaking down various beta-lactam antibiotics. The emergence and spread of bacteria producing these enzymes have contributed to the growing problem of antibiotic resistance, making it increasingly challenging to treat infections caused by these organisms.

To overcome this issue, researchers have developed beta-lactamase inhibitors, which are drugs that can bind to and inhibit the activity of these enzymes, thus restoring the effectiveness of certain beta-lactam antibiotics. Examples of such combinations include amoxicillin/clavulanate (Augmentin) and piperacillin/tazobactam (Zosyn).

"Klebsiella oxytoca" is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that is part of the family Enterobacteriaceae. It is a normal inhabitant of the human gastrointestinal tract and can be found in soil, water, and plants. In clinical settings, K. oxytoca can cause various types of infections, including pneumonia, bloodstream infections, wound infections, and urinary tract infections. It is known to produce a variety of beta-lactamases, enzymes that can hydrolyze and inactivate certain antibiotics, making it resistant to some forms of treatment. Its identification is important for appropriate antimicrobial therapy and infection control measures.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Carbapenems are a class of broad-spectrum beta-lactam antibiotics, which are used to treat severe infections caused by bacteria that are resistant to other antibiotics. They have a similar chemical structure to penicillins and cephalosporins but are more resistant to the enzymes produced by bacteria that can inactivate these other antibiotics. Carbapenems are often reserved for use in serious infections caused by multidrug-resistant organisms, and they are typically given intravenously in a hospital setting. Examples of carbapenems include imipenem, meropenem, doripenem, and ertapenem.

Beta-lactam resistance is a type of antibiotic resistance in which bacteria have developed the ability to inactivate or circumvent the action of beta-lactam antibiotics. Beta-lactams are a class of antibiotics that include penicillins, cephalosporins, carbapenems, and monobactams. They work by binding to and inhibiting the activity of enzymes called penicillin-binding proteins (PBPs), which are essential for bacterial cell wall synthesis.

Bacteria can develop beta-lactam resistance through several mechanisms:

1. Production of beta-lactamases: These are enzymes that bacteria produce to break down and inactivate beta-lactam antibiotics. Some bacteria have acquired genes that encode for beta-lactamases that can hydrolyze and destroy the beta-lactam ring, rendering the antibiotic ineffective.
2. Alteration of PBPs: Bacteria can also develop mutations in their PBPs that make them less susceptible to beta-lactams. These alterations can reduce the affinity of PBPs for beta-lactams or change their conformation, preventing the antibiotic from binding effectively.
3. Efflux pumps: Bacteria can also develop efflux pumps that actively pump beta-lactam antibiotics out of the cell, reducing their intracellular concentration and limiting their effectiveness.
4. Biofilm formation: Some bacteria can form biofilms, which are communities of microorganisms that adhere to surfaces and are encased in a protective matrix. Biofilms can make bacteria more resistant to beta-lactams by preventing the antibiotics from reaching their targets.

Beta-lactam resistance is a significant public health concern because it limits the effectiveness of these important antibiotics. The overuse and misuse of beta-lactams have contributed to the emergence and spread of resistant bacteria, making it essential to use these antibiotics judiciously and develop new strategies to combat bacterial resistance.

Enterobacteriaceae is a family of gram-negative, rod-shaped bacteria that are commonly found in the intestines of humans and animals. Many species within this family are capable of causing various types of infections, particularly in individuals with weakened immune systems. Some common examples of Enterobacteriaceae include Escherichia coli (E. coli), Klebsiella pneumoniae, Proteus mirabilis, and Salmonella enterica.

These bacteria are typically characterized by their ability to ferment various sugars and produce acid and gas as byproducts. They can also be distinguished by their biochemical reactions, such as their ability to produce certain enzymes or resist specific antibiotics. Infections caused by Enterobacteriaceae can range from mild to severe, depending on the species involved and the overall health of the infected individual.

Some infections caused by Enterobacteriaceae include urinary tract infections, pneumonia, bloodstream infections, and foodborne illnesses. Proper hygiene, such as handwashing and safe food handling practices, can help prevent the spread of these bacteria and reduce the risk of infection.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

Nitrogenase is not a medical term, but a biological term used in the field of microbiology and biochemistry. It refers to an enzyme complex found in certain bacteria and archaea that have the ability to fix nitrogen gas (N2) from the atmosphere into ammonia (NH3), a form of nitrogen that can be utilized by plants and other organisms for growth and development. This process is known as biological nitrogen fixation, which is essential for maintaining the global nitrogen cycle and supporting life on Earth.

The medical field may refer to nitrogenase in relation to human health in the context of understanding the role of nitrogen-fixing bacteria in soil fertility and their impact on agriculture and food production. However, there is no direct medical definition or application for nitrogenase.

A liver abscess is a localized collection of pus within the liver tissue caused by an infection. It can result from various sources such as bacterial or amebic infections that spread through the bloodstream, bile ducts, or directly from nearby organs. The abscess may cause symptoms like fever, pain in the upper right abdomen, nausea, vomiting, and weight loss. If left untreated, a liver abscess can lead to serious complications, including sepsis and organ failure. Diagnosis typically involves imaging tests like ultrasound or CT scan, followed by drainage of the pus and antibiotic treatment.

Nitrogen fixation is a process by which nitrogen gas (N2) in the air is converted into ammonia (NH3) or other chemically reactive forms, making it available to plants and other organisms for use as a nutrient. This process is essential for the nitrogen cycle and for the growth of many types of plants, as most plants cannot utilize nitrogen gas directly from the air.

In the medical field, nitrogen fixation is not a commonly used term. However, in the context of microbiology and infectious diseases, some bacteria are capable of fixing nitrogen and this ability can contribute to their pathogenicity. For example, certain species of bacteria that colonize the human body, such as those found in the gut or on the skin, may be able to fix nitrogen and use it for their own growth and survival. In some cases, these bacteria may also release fixed nitrogen into the environment, which can have implications for the ecology and health of the host and surrounding ecosystems.

Multiple bacterial drug resistance (MDR) is a medical term that refers to the resistance of multiple strains of bacteria to several antibiotics or antimicrobial agents. This means that these bacteria have developed mechanisms that enable them to survive and multiply despite being exposed to drugs that were previously effective in treating infections caused by them.

MDR is a significant public health concern because it limits the treatment options available for bacterial infections, making them more difficult and expensive to treat. In some cases, MDR bacteria may cause severe or life-threatening infections that are resistant to all available antibiotics, leaving doctors with few or no effective therapeutic options.

MDR can arise due to various mechanisms, including the production of enzymes that inactivate antibiotics, changes in bacterial cell membrane permeability that prevent antibiotics from entering the bacteria, and the development of efflux pumps that expel antibiotics out of the bacteria. The misuse or overuse of antibiotics is a significant contributor to the emergence and spread of MDR bacteria.

Preventing and controlling the spread of MDR bacteria requires a multifaceted approach, including the judicious use of antibiotics, infection control measures, surveillance, and research into new antimicrobial agents.

Beta-lactams are a class of antibiotics that include penicillins, cephalosporins, carbapenems, and monobactams. They contain a beta-lactam ring in their chemical structure, which is responsible for their antibacterial activity. The beta-lactam ring inhibits the bacterial enzymes necessary for cell wall synthesis, leading to bacterial death. Beta-lactams are commonly used to treat a wide range of bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and bone and joint infections. However, some bacteria have developed resistance to beta-lactams through the production of beta-lactamases, enzymes that can break down the beta-lactam ring and render the antibiotic ineffective. To overcome this resistance, beta-lactam antibiotics are often combined with beta-lactamase inhibitors, which protect the beta-lactam ring from degradation.

Bacterial DNA refers to the genetic material found in bacteria. It is composed of a double-stranded helix containing four nucleotide bases - adenine (A), thymine (T), guanine (G), and cytosine (C) - that are linked together by phosphodiester bonds. The sequence of these bases in the DNA molecule carries the genetic information necessary for the growth, development, and reproduction of bacteria.

Bacterial DNA is circular in most bacterial species, although some have linear chromosomes. In addition to the main chromosome, many bacteria also contain small circular pieces of DNA called plasmids that can carry additional genes and provide resistance to antibiotics or other environmental stressors.

Unlike eukaryotic cells, which have their DNA enclosed within a nucleus, bacterial DNA is present in the cytoplasm of the cell, where it is in direct contact with the cell's metabolic machinery. This allows for rapid gene expression and regulation in response to changing environmental conditions.

Bacterial drug resistance is a type of antimicrobial resistance that occurs when bacteria evolve the ability to survive and reproduce in the presence of drugs (such as antibiotics) that would normally kill them or inhibit their growth. This can happen due to various mechanisms, including genetic mutations or the acquisition of resistance genes from other bacteria.

As a result, bacterial infections may become more difficult to treat, requiring higher doses of medication, alternative drugs, or longer treatment courses. In some cases, drug-resistant infections can lead to serious health complications, increased healthcare costs, and higher mortality rates.

Examples of bacterial drug resistance include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and multidrug-resistant tuberculosis (MDR-TB). Preventing the spread of bacterial drug resistance is crucial for maintaining effective treatments for infectious diseases.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Enterobacteriaceae are a large family of gram-negative bacteria that are commonly found in the human gut and surrounding environment. Infections caused by Enterobacteriaceae can occur when these bacteria enter parts of the body where they are not normally present, such as the bloodstream, urinary tract, or abdominal cavity.

Enterobacteriaceae infections can cause a range of symptoms depending on the site of infection. For example:

* Urinary tract infections (UTIs) caused by Enterobacteriaceae may cause symptoms such as frequent urination, pain or burning during urination, and lower abdominal pain.
* Bloodstream infections (bacteremia) caused by Enterobacteriaceae can cause fever, chills, and sepsis, a potentially life-threatening condition characterized by a whole-body inflammatory response to infection.
* Pneumonia caused by Enterobacteriaceae may cause cough, chest pain, and difficulty breathing.
* Intra-abdominal infections (such as appendicitis or diverticulitis) caused by Enterobacteriaceae can cause abdominal pain, fever, and changes in bowel habits.

Enterobacteriaceae infections are typically treated with antibiotics, but the increasing prevalence of antibiotic-resistant strains of these bacteria has made treatment more challenging in recent years. Preventing the spread of Enterobacteriaceae in healthcare settings and promoting good hygiene practices can help reduce the risk of infection.

A plasmid is a small, circular, double-stranded DNA molecule that is separate from the chromosomal DNA of a bacterium or other organism. Plasmids are typically not essential for the survival of the organism, but they can confer beneficial traits such as antibiotic resistance or the ability to degrade certain types of pollutants.

Plasmids are capable of replicating independently of the chromosomal DNA and can be transferred between bacteria through a process called conjugation. They often contain genes that provide resistance to antibiotics, heavy metals, and other environmental stressors. Plasmids have also been engineered for use in molecular biology as cloning vectors, allowing scientists to replicate and manipulate specific DNA sequences.

Plasmids are important tools in genetic engineering and biotechnology because they can be easily manipulated and transferred between organisms. They have been used to produce vaccines, diagnostic tests, and genetically modified organisms (GMOs) for various applications, including agriculture, medicine, and industry.

A bacterial gene is a segment of DNA (or RNA in some viruses) that contains the genetic information necessary for the synthesis of a functional bacterial protein or RNA molecule. These genes are responsible for encoding various characteristics and functions of bacteria such as metabolism, reproduction, and resistance to antibiotics. They can be transmitted between bacteria through horizontal gene transfer mechanisms like conjugation, transformation, and transduction. Bacterial genes are often organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule.

It's important to note that the term "bacterial gene" is used to describe genetic elements found in bacteria, but not all genetic elements in bacteria are considered genes. For example, some DNA sequences may not encode functional products and are therefore not considered genes. Additionally, some bacterial genes may be plasmid-borne or phage-borne, rather than being located on the bacterial chromosome.

Cephalosporins are a class of antibiotics that are derived from the fungus Acremonium, originally isolated from seawater and cow dung. They have a similar chemical structure to penicillin and share a common four-membered beta-lactam ring in their molecular structure.

Cephalosporins work by inhibiting the synthesis of bacterial cell walls, which ultimately leads to bacterial death. They are broad-spectrum antibiotics, meaning they are effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

There are several generations of cephalosporins, each with different spectra of activity and pharmacokinetic properties. The first generation cephalosporins have a narrow spectrum of activity and are primarily used to treat infections caused by susceptible Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae.

Second-generation cephalosporins have an expanded spectrum of activity that includes some Gram-negative organisms, such as Escherichia coli and Haemophilus influenzae. Third-generation cephalosporins have even broader spectra of activity and are effective against many resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Klebsiella pneumoniae.

Fourth-generation cephalosporins have activity against both Gram-positive and Gram-negative organisms, including some that are resistant to other antibiotics. They are often reserved for the treatment of serious infections caused by multidrug-resistant bacteria.

Cephalosporins are generally well tolerated, but like penicillin, they can cause allergic reactions in some individuals. Cross-reactivity between cephalosporins and penicillin is estimated to occur in 5-10% of patients with a history of penicillin allergy. Other potential adverse effects include gastrointestinal symptoms (such as nausea, vomiting, and diarrhea), neurotoxicity, and nephrotoxicity.

Cross infection, also known as cross-contamination, is the transmission of infectious agents or diseases between patients in a healthcare setting. This can occur through various means such as contaminated equipment, surfaces, hands of healthcare workers, or the air. It is an important concern in medical settings and measures are taken to prevent its occurrence, including proper hand hygiene, use of personal protective equipment (PPE), environmental cleaning and disinfection, and safe injection practices.

Mycoplasma pneumonia is a type of atypical pneumonia, which is caused by the bacterium Mycoplasma pneumoniae. This organism is not a true bacterium, but rather the smallest free-living organisms known. They lack a cell wall and have a unique mode of reproduction.

Mycoplasma pneumonia infection typically occurs in small outbreaks or sporadically, often in crowded settings such as schools, colleges, and military barracks. It can also be acquired in the community. The illness is often mild and self-limiting, but it can also cause severe pneumonia and extra-pulmonary manifestations.

The symptoms of Mycoplasma pneumonia are typically less severe than those caused by typical bacterial pneumonia and may include a persistent cough that may be dry or produce small amounts of mucus, fatigue, fever, headache, sore throat, and chest pain. The infection can also cause extrapulmonary manifestations such as skin rashes, joint pain, and neurological symptoms.

Diagnosis of Mycoplasma pneumonia is often challenging because the organism is difficult to culture, and serological tests may take several weeks to become positive. PCR-based tests are now available and can provide a rapid diagnosis.

Treatment typically involves antibiotics such as macrolides (e.g., azithromycin), tetracyclines (e.g., doxycycline), or fluoroquinolones (e.g., levofloxacin). However, because Mycoplasma pneumonia is often self-limiting, antibiotic treatment may not shorten the duration of illness but can help prevent complications and reduce transmission.

Enterobacter is a genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, including in soil, water, and the gastrointestinal tracts of humans and animals. These bacteria are members of the family Enterobacteriaceae and are known to cause a variety of infections in humans, particularly in healthcare settings.

Enterobacter species are capable of causing a range of infections, including urinary tract infections, pneumonia, bacteremia, and wound infections. They are often resistant to multiple antibiotics, which can make treatment challenging. Infections with Enterobacter are typically treated with broad-spectrum antibiotics that are effective against gram-negative bacteria.

It's worth noting that while Enterobacter species can cause infections, they are also a normal part of the microbiota found in the human gut and usually do not cause harm in healthy individuals. However, if the bacterium enters the bloodstream or other sterile sites in the body, it can cause infection and illness.

Gram-negative bacteria are a type of bacteria that do not retain the crystal violet stain used in the Gram staining method, a standard technique used in microbiology to classify and identify different types of bacteria based on their structural differences. This method was developed by Hans Christian Gram in 1884.

The primary characteristic distinguishing Gram-negative bacteria from Gram-positive bacteria is the composition and structure of their cell walls:

1. Cell wall: Gram-negative bacteria have a thin peptidoglycan layer, making it more susceptible to damage and less rigid compared to Gram-positive bacteria.
2. Outer membrane: They possess an additional outer membrane that contains lipopolysaccharides (LPS), which are endotoxins that can trigger strong immune responses in humans and animals. The outer membrane also contains proteins, known as porins, which form channels for the passage of molecules into and out of the cell.
3. Periplasm: Between the inner and outer membranes lies a compartment called the periplasm, where various enzymes and other molecules are located.

Some examples of Gram-negative bacteria include Escherichia coli (E. coli), Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella enterica, Shigella spp., and Neisseria meningitidis. These bacteria are often associated with various infections, such as urinary tract infections, pneumonia, sepsis, and meningitis. Due to their complex cell wall structure, Gram-negative bacteria can be more resistant to certain antibiotics, making them a significant concern in healthcare settings.

Ceftazidime is a third-generation cephalosporin antibiotic, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, leading to bacterial cell death. Ceftazidime has a broad spectrum of activity and is effective against many Gram-negative and some Gram-positive bacteria.

It is often used to treat serious infections such as pneumonia, urinary tract infections, and sepsis, particularly when they are caused by antibiotic-resistant bacteria. Ceftazidime is also commonly used in combination with other antibiotics to treat complicated abdominal infections, bone and joint infections, and hospital-acquired pneumonia.

Like all antibiotics, ceftazidime can cause side effects, including diarrhea, nausea, vomiting, and allergic reactions. It may also affect the kidneys and should be used with caution in patients with impaired renal function. Ceftazidime is available in both intravenous (IV) and oral forms.

Bacterial pneumonia is a type of lung infection that's caused by bacteria. It can affect people of any age, but it's more common in older adults, young children, and people with certain health conditions or weakened immune systems. The symptoms of bacterial pneumonia can vary, but they often include cough, chest pain, fever, chills, and difficulty breathing.

The most common type of bacteria that causes pneumonia is Streptococcus pneumoniae (pneumococcus). Other types of bacteria that can cause pneumonia include Haemophilus influenzae, Staphylococcus aureus, and Mycoplasma pneumoniae.

Bacterial pneumonia is usually treated with antibiotics, which are medications that kill bacteria. The specific type of antibiotic used will depend on the type of bacteria causing the infection. It's important to take all of the prescribed medication as directed, even if you start feeling better, to ensure that the infection is completely cleared and to prevent the development of antibiotic resistance.

In severe cases of bacterial pneumonia, hospitalization may be necessary for close monitoring and treatment with intravenous antibiotics and other supportive care.

Pneumococcal infections are illnesses caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium can infect different parts of the body, including the lungs (pneumonia), blood (bacteremia or sepsis), and the covering of the brain and spinal cord (meningitis). Pneumococcal infections can also cause ear infections and sinus infections. The bacteria spread through close contact with an infected person, who may spread the bacteria by coughing or sneezing. People with weakened immune systems, children under 2 years of age, adults over 65, and those with certain medical conditions are at increased risk for developing pneumococcal infections.

A pyogenic liver abscess is a localized collection of pus within the liver parenchyma caused by an infectious process. It's typically characterized by the presence of a purulent material, which can be composed of white blood cells (neutrophils), necrotic debris, and microorganisms. The infection usually spreads to the liver through the hepatic blood vessels from a primary focus of infection elsewhere in the body, such as the gastrointestinal tract, lungs, or dental sources.

The most common causative organisms are Escherichia coli, Klebsiella pneumoniae, and Streptococcus species; however, anaerobes and fungi can also be responsible in certain populations. The clinical presentation of pyogenic liver abscess may include fever, chills, right upper quadrant abdominal pain, nausea, vomiting, and signs of systemic infection. Diagnosis is usually confirmed with imaging techniques such as ultrasound or CT scan, followed by aspiration and culture of the pus for identification of the causative organism(s) and antibiogram-guided antimicrobial therapy. Drainage of the abscess, either percutaneously or surgically, might be required in specific cases to ensure resolution and prevent recurrence.

Bacterial capsules are slimy, gel-like layers that surround many types of bacteria. They are made up of polysaccharides, proteins, or lipopolysaccharides and are synthesized by the bacterial cell. These capsules play a crucial role in the virulence and pathogenicity of bacteria as they help the bacteria to evade the host's immune system and promote their survival and colonization within the host. The presence of a capsule can also contribute to the bacteria's resistance to desiccation, phagocytosis, and antibiotics.

The chemical composition and structure of bacterial capsules vary among different species of bacteria, which is one factor that contributes to their serological specificity and allows for their identification and classification using methods such as the Quellung reaction or immunofluorescence microscopy.

Molybdoferredoxin is not a widely recognized medical term, but it is a term used in biochemistry and molecular biology to describe a type of protein that contains molybdenum and iron-sulfur clusters as cofactors. These proteins are involved in various redox reactions in the body, particularly in the metabolism of certain amino acids, nucleotides, and other small molecules.

Molybdoferredoxins are found in many organisms, including bacteria, archaea, and eukaryotes (including humans). In humans, molybdoferredoxins play important roles in several metabolic pathways, such as the oxidation of sulfite to sulfate and the reduction of nitrate to nitrite.

Deficiencies or mutations in molybdoferredoxin-related genes can lead to various metabolic disorders, including molybdenum cofactor deficiency, a rare genetic disorder that affects multiple enzymes requiring molybdenum as a cofactor.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Pulsed-field gel electrophoresis (PFGE) is a type of electrophoresis technique used in molecular biology to separate DNA molecules based on their size and conformation. In this method, the electric field is applied in varying directions, which allows for the separation of large DNA fragments that are difficult to separate using traditional gel electrophoresis methods.

The DNA sample is prepared by embedding it in a semi-solid matrix, such as agarose or polyacrylamide, and then subjected to an electric field that periodically changes direction. This causes the DNA molecules to reorient themselves in response to the changing electric field, which results in the separation of the DNA fragments based on their size and shape.

PFGE is a powerful tool for molecular biology research and has many applications, including the identification and characterization of bacterial pathogens, the analysis of genomic DNA, and the study of gene organization and regulation. It is also used in forensic science to analyze DNA evidence in criminal investigations.

Genetic conjugation is a type of genetic transfer that occurs between bacterial cells. It involves the process of one bacterium (the donor) transferring a piece of its DNA to another bacterium (the recipient) through direct contact or via a bridge-like connection called a pilus. This transferred DNA may contain genes that provide the recipient cell with new traits, such as antibiotic resistance or virulence factors, which can make the bacteria more harmful or difficult to treat. Genetic conjugation is an important mechanism for the spread of antibiotic resistance and other traits among bacterial populations.

Klebsiella is a genus of Gram-negative, facultatively anaerobic, encapsulated, non-motile, rod-shaped bacteria that are part of the family Enterobacteriaceae. They are commonly found in the normal microbiota of the mouth, skin, and intestines, but can also cause various types of infections, particularly in individuals with weakened immune systems.

Klebsiella pneumoniae is the most common species and can cause pneumonia, urinary tract infections, bloodstream infections, and wound infections. Other Klebsiella species, such as K. oxytoca, can also cause similar types of infections. These bacteria are resistant to many antibiotics, making them difficult to treat and a significant public health concern.

Chlamydophila infections are caused by bacteria belonging to the genus Chlamydophila, which includes several species that can infect humans and animals. The two most common species that cause infections in humans are Chlamydophila pneumoniae and Chlamydophila trachomatis.

Chlamydophila pneumoniae is responsible for respiratory infections, including pneumonia, bronchitis, and sinusitis. It is usually spread through respiratory droplets and can cause both mild and severe illnesses.

Chlamydophila trachomatis causes a wide range of infections, depending on the serovar (strain) involved. The most common types of Chlamydia trachomatis infections include:

1. Nongonococcal urethritis and cervicitis: These are sexually transmitted infections that can cause inflammation of the urethra and cervix, respectively. Symptoms may include discharge, pain during urination, and painful intercourse.
2. Lymphogranuloma venereum (LGV): This is a sexually transmitted infection that primarily affects the lymphatic system. It can cause symptoms such as genital ulcers, swollen lymph nodes, and rectal pain and discharge.
3. Trachoma: This is an eye infection caused by a specific serovar of Chlamydia trachomatis. It is the leading infectious cause of blindness worldwide and primarily affects populations in developing countries with poor sanitation.
4. Inclusion conjunctivitis: This is an eye infection that mainly affects newborns, causing inflammation of the conjunctiva (the membrane lining the eyelids). It can be transmitted from mother to child during childbirth and may lead to vision problems if left untreated.

Diagnosis of Chlamydophila infections typically involves laboratory tests such as nucleic acid amplification tests (NAATs) or culture methods. Treatment usually consists of antibiotics, such as azithromycin or doxycycline, and may involve additional measures depending on the site and severity of infection. Prevention strategies include practicing safe sex, maintaining good hygiene, and receiving appropriate vaccinations for at-risk populations.

Bacteremia is the presence of bacteria in the bloodstream. It is a medical condition that occurs when bacteria from another source, such as an infection in another part of the body, enter the bloodstream. Bacteremia can cause symptoms such as fever, chills, and rapid heart rate, and it can lead to serious complications such as sepsis if not treated promptly with antibiotics.

Bacteremia is often a result of an infection elsewhere in the body that allows bacteria to enter the bloodstream. This can happen through various routes, such as during medical procedures, intravenous (IV) drug use, or from infected wounds or devices that come into contact with the bloodstream. In some cases, bacteremia may also occur without any obvious source of infection.

It is important to note that not all bacteria in the bloodstream cause harm, and some people may have bacteria in their blood without showing any symptoms. However, if bacteria in the bloodstream multiply and cause an immune response, it can lead to bacteremia and potentially serious complications.

Thienamycins are a group of antibiotics that are characterized by their beta-lactam structure. They belong to the class of carbapenems and are known for their broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria, including many that are resistant to other antibiotics. Thienamycins inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), which leads to bacterial cell death.

Thienamycin itself is not used clinically due to its instability, but several semi-synthetic derivatives of thienamycin have been developed and are used in the treatment of serious infections caused by multidrug-resistant bacteria. Examples of thienamycin derivatives include imipenem, meropenem, and ertapenem. These antibiotics are often reserved for the treatment of severe infections that are unresponsive to other antibiotics due to their potential to select for resistant bacteria and their high cost.

Cefotaxime is a third-generation cephalosporin antibiotic, which is used to treat a variety of bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall. Cefotaxime has a broad spectrum of activity and is effective against many Gram-positive and Gram-negative bacteria, including some that are resistant to other antibiotics.

Cefotaxime is often used to treat serious infections such as pneumonia, meningitis, and sepsis. It may also be used to prevent infections during surgery or in people with weakened immune systems. The drug is administered intravenously or intramuscularly, and its dosage depends on the type and severity of the infection being treated.

Like all antibiotics, cefotaxime can cause side effects, including diarrhea, nausea, vomiting, and rash. In rare cases, it may cause serious allergic reactions or damage to the kidneys or liver. It is important to follow the prescribing physician's instructions carefully when taking this medication.

Anti-infective agents are a class of medications that are used to treat infections caused by various microorganisms such as bacteria, viruses, fungi, and parasites. These agents work by either killing the microorganism or inhibiting its growth, thereby helping to control the infection and alleviate symptoms.

There are several types of anti-infective agents, including:

1. Antibiotics: These are medications that are used to treat bacterial infections. They work by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic).
2. Antivirals: These are medications that are used to treat viral infections. They work by interfering with the replication of the virus, preventing it from spreading and causing further damage.
3. Antifungals: These are medications that are used to treat fungal infections. They work by disrupting the cell membrane of the fungus, killing it or inhibiting its growth.
4. Antiparasitics: These are medications that are used to treat parasitic infections. They work by either killing the parasite or inhibiting its growth and reproduction.

It is important to note that anti-infective agents are not effective against all types of infections, and it is essential to use them appropriately to avoid the development of drug-resistant strains of microorganisms.

Acetylene is defined as a colorless, highly flammable gas with a distinctive odor, having the chemical formula C2H2. It is the simplest and lightest hydrocarbon in which two carbon atoms are bonded together by a triple bond. Acetylene is used as a fuel in welding and cutting torches, and it can also be converted into other chemicals, such as vinyl acetate and acetic acid. In medical terms, acetylene is not a substance that is commonly used or discussed.

Imipenem is an antibiotic medication that belongs to the class of carbapenems. It is used to treat various types of bacterial infections, including pneumonia, sepsis, and skin infections. Imipenem works by inhibiting the synthesis of bacterial cell walls, leading to bacterial death.

Imipenem is often combined with another medication called cilastatin, which helps to prevent the breakdown of imipenem in the body and increase its effectiveness. The combination of imipenem and cilastatin is available under the brand name Primaxin.

Like other antibiotics, imipenem should be used with caution and only when necessary, as overuse can lead to antibiotic resistance. It is important to follow the prescribing physician's instructions carefully and complete the full course of treatment, even if symptoms improve before the medication is finished.

Gram-negative bacterial infections refer to illnesses or diseases caused by Gram-negative bacteria, which are a group of bacteria that do not retain crystal violet dye during the Gram staining procedure used in microbiology. This characteristic is due to the structure of their cell walls, which contain a thin layer of peptidoglycan and an outer membrane composed of lipopolysaccharides (LPS), proteins, and phospholipids.

The LPS component of the outer membrane is responsible for the endotoxic properties of Gram-negative bacteria, which can lead to severe inflammatory responses in the host. Common Gram-negative bacterial pathogens include Escherichia coli (E. coli), Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Proteus mirabilis, among others.

Gram-negative bacterial infections can cause a wide range of clinical syndromes, such as pneumonia, urinary tract infections, bloodstream infections, meningitis, and soft tissue infections. The severity of these infections can vary from mild to life-threatening, depending on the patient's immune status, the site of infection, and the virulence of the bacterial strain.

Effective antibiotic therapy is crucial for treating Gram-negative bacterial infections, but the increasing prevalence of multidrug-resistant strains has become a significant global health concern. Therefore, accurate diagnosis and appropriate antimicrobial stewardship are essential to ensure optimal patient outcomes and prevent further spread of resistance.

Cephalosporin resistance refers to the ability of bacteria to resist the antibacterial effects of cephalosporins, a group of widely used antibiotics. These drugs work by interfering with the bacterial cell wall synthesis, thereby inhibiting bacterial growth and reproduction. However, some bacteria have developed mechanisms that enable them to survive in the presence of cephalosporins.

There are several ways in which bacteria can become resistant to cephalosporins. One common mechanism is through the production of beta-lactamases, enzymes that can break down the beta-lactam ring structure of cephalosporins and other related antibiotics. This makes the drugs ineffective against the bacteria.

Another mechanism of resistance involves changes in the bacterial cell membrane or the penicillin-binding proteins (PBPs) that prevent the binding of cephalosporins to their target sites. These changes can occur due to genetic mutations or the acquisition of new genes through horizontal gene transfer.

Cephalosporin resistance is a significant public health concern, as it can limit the treatment options for bacterial infections and increase the risk of morbidity and mortality. The overuse and misuse of antibiotics are major drivers of antibiotic resistance, including cephalosporin resistance. Therefore, it is essential to use these drugs judiciously and follow proper infection prevention and control measures to prevent the spread of resistant bacteria.

A hospital is a healthcare facility where patients receive medical treatment, diagnosis, and care for various health conditions, injuries, or diseases. It is typically staffed with medical professionals such as doctors, nurses, and other healthcare workers who provide round-the-clock medical services. Hospitals may offer inpatient (overnight) stays or outpatient (same-day) services, depending on the nature of the treatment required. They are equipped with various medical facilities like operating rooms, diagnostic equipment, intensive care units (ICUs), and emergency departments to handle a wide range of medical situations. Hospitals may specialize in specific areas of medicine, such as pediatrics, geriatrics, oncology, or trauma care.

Colistin is an antibiotic that belongs to a class of drugs called polymyxins. It is primarily used to treat infections caused by Gram-negative bacteria, including some that are resistant to other antibiotics. Colistin works by disrupting the bacterial cell membrane and causing the bacterium to lose essential components, leading to its death.

Colistin can be administered intravenously or inhaled, depending on the type of infection being treated. It is important to note that colistin has a narrow therapeutic index, meaning that there is a small difference between the effective dose and the toxic dose. Therefore, it must be used with caution and under the close supervision of a healthcare professional.

Common side effects of colistin include kidney damage, nerve damage, and muscle weakness. It may also cause allergic reactions in some people. Colistin should not be used during pregnancy or breastfeeding unless the benefits outweigh the risks.

Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.

The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.

In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.

DNA Sequence Analysis is the systematic determination of the order of nucleotides in a DNA molecule. It is a critical component of modern molecular biology, genetics, and genetic engineering. The process involves determining the exact order of the four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - in a DNA molecule or fragment. This information is used in various applications such as identifying gene mutations, studying evolutionary relationships, developing molecular markers for breeding, and diagnosing genetic diseases.

The process of DNA Sequence Analysis typically involves several steps, including DNA extraction, PCR amplification (if necessary), purification, sequencing reaction, and electrophoresis. The resulting data is then analyzed using specialized software to determine the exact sequence of nucleotides.

In recent years, high-throughput DNA sequencing technologies have revolutionized the field of genomics, enabling the rapid and cost-effective sequencing of entire genomes. This has led to an explosion of genomic data and new insights into the genetic basis of many diseases and traits.

Bacterial polysaccharides are complex carbohydrates that consist of long chains of sugar molecules (monosaccharides) linked together by glycosidic bonds. They are produced and used by bacteria for various purposes such as:

1. Structural components: Bacterial polysaccharides, such as peptidoglycan and lipopolysaccharide (LPS), play a crucial role in maintaining the structural integrity of bacterial cells. Peptidoglycan is a major component of the bacterial cell wall, while LPS forms the outer layer of the outer membrane in gram-negative bacteria.
2. Nutrient storage: Some bacteria synthesize and store polysaccharides as an energy reserve, similar to how plants store starch. These polysaccharides can be broken down and utilized by the bacterium when needed.
3. Virulence factors: Bacterial polysaccharides can also function as virulence factors, contributing to the pathogenesis of bacterial infections. For example, certain bacteria produce capsular polysaccharides (CPS) that surround and protect the bacterial cells from host immune defenses, allowing them to evade phagocytosis and persist within the host.
4. Adhesins: Some polysaccharides act as adhesins, facilitating the attachment of bacteria to surfaces or host cells. This is important for biofilm formation, which helps bacteria resist environmental stresses and antibiotic treatments.
5. Antigenic properties: Bacterial polysaccharides can be highly antigenic, eliciting an immune response in the host. The antigenicity of these molecules can vary between different bacterial species or even strains within a species, making them useful as targets for vaccines and diagnostic tests.

In summary, bacterial polysaccharides are complex carbohydrates that serve various functions in bacteria, including structural support, nutrient storage, virulence factor production, adhesion, and antigenicity.

Microbial drug resistance is a significant medical issue that refers to the ability of microorganisms (such as bacteria, viruses, fungi, or parasites) to withstand or survive exposure to drugs or medications designed to kill them or limit their growth. This phenomenon has become a major global health concern, particularly in the context of bacterial infections, where it is also known as antibiotic resistance.

Drug resistance arises due to genetic changes in microorganisms that enable them to modify or bypass the effects of antimicrobial agents. These genetic alterations can be caused by mutations or the acquisition of resistance genes through horizontal gene transfer. The resistant microbes then replicate and multiply, forming populations that are increasingly difficult to eradicate with conventional treatments.

The consequences of drug-resistant infections include increased morbidity, mortality, healthcare costs, and the potential for widespread outbreaks. Factors contributing to the emergence and spread of microbial drug resistance include the overuse or misuse of antimicrobials, poor infection control practices, and inadequate surveillance systems.

To address this challenge, it is crucial to promote prudent antibiotic use, strengthen infection prevention and control measures, develop new antimicrobial agents, and invest in research to better understand the mechanisms underlying drug resistance.

'Enterobacter cloacae' is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, including in soil, water, and the gastrointestinal tracts of humans and animals. They are part of the family Enterobacteriaceae and can cause various types of infections in humans, particularly in individuals with weakened immune systems or underlying medical conditions.

E. cloacae is known to be an opportunistic pathogen, which means that it typically does not cause disease in healthy people but can take advantage of a weakened host to cause infection. It can cause a range of infections, including urinary tract infections, pneumonia, bacteremia (bloodstream infections), and wound infections.

E. cloacae is often resistant to multiple antibiotics, which can make treatment challenging. In recent years, there has been an increase in the number of E. cloacae isolates that are resistant to carbapenems, a class of antibiotics that are typically reserved for treating serious infections caused by multidrug-resistant bacteria. This has led to concerns about the potential for untreatable infections caused by this organism.

Multilocus Sequence Typing (MLST) is a standardized method used in microbiology to characterize and identify bacterial isolates at the subspecies level. It is based on the sequencing of several (usually 7-10) housekeeping genes, which are essential for the survival of the organism and have a low rate of mutation. The sequence type (ST) is determined by the specific alleles present at each locus, creating a unique profile that can be used to compare and cluster isolates into clonal complexes or sequence types. This method provides high-resolution discrimination between closely related strains and has been widely adopted for molecular epidemiology, infection control, and population genetics studies of bacterial pathogens.

Pneumonia, pneumococcal is a type of pneumonia caused by the bacterium Streptococcus pneumoniae (also known as pneumococcus). This bacteria can colonize the upper respiratory tract and occasionally invade the lower respiratory tract, causing infection.

Pneumococcal pneumonia can affect people of any age but is most common in young children, older adults, and those with weakened immune systems. The symptoms of pneumococcal pneumonia include fever, chills, cough, chest pain, shortness of breath, and rapid breathing. In severe cases, it can lead to complications such as bacteremia (bacterial infection in the blood), meningitis (inflammation of the membranes surrounding the brain and spinal cord), and respiratory failure.

Pneumococcal pneumonia can be prevented through vaccination with the pneumococcal conjugate vaccine (PCV) or the pneumococcal polysaccharide vaccine (PPSV). These vaccines protect against the most common strains of Streptococcus pneumoniae that cause invasive disease. It is also important to practice good hygiene, such as covering the mouth and nose when coughing or sneezing, and washing hands frequently, to prevent the spread of pneumococcal bacteria.

Minocycline is an antibiotic medication that belongs to the tetracycline class. Medically, it is defined as a semisynthetic derivative of tetracycline and has a broader spectrum of activity compared to other tetracyclines. It is bacteriostatic, meaning it inhibits bacterial growth rather than killing them outright.

Minocycline is commonly used to treat various infections caused by susceptible bacteria, including acne, respiratory infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted diseases. Additionally, it has been found to have anti-inflammatory properties and is being investigated for its potential use in treating neurological disorders such as multiple sclerosis and Alzheimer's disease.

As with all antibiotics, minocycline should be taken under the guidance of a healthcare professional, and its usage should be based on the results of bacterial culture and sensitivity testing to ensure its effectiveness against the specific bacteria causing the infection.

Escherichia coli (E. coli) infections refer to illnesses caused by the bacterium E. coli, which can cause a range of symptoms depending on the specific strain and site of infection. The majority of E. coli strains are harmless and live in the intestines of healthy humans and animals. However, some strains, particularly those that produce Shiga toxins, can cause severe illness.

E. coli infections can occur through various routes, including contaminated food or water, person-to-person contact, or direct contact with animals or their environments. Common symptoms of E. coli infections include diarrhea (often bloody), abdominal cramps, nausea, and vomiting. In severe cases, complications such as hemolytic uremic syndrome (HUS) can occur, which may lead to kidney failure and other long-term health problems.

Preventing E. coli infections involves practicing good hygiene, cooking meats thoroughly, avoiding cross-contamination of food during preparation, washing fruits and vegetables before eating, and avoiding unpasteurized dairy products and juices. Prompt medical attention is necessary if symptoms of an E. coli infection are suspected to prevent potential complications.

Cefoxitin is a type of antibiotic known as a cephamycin, which is a subclass of the larger group of antibiotics called cephalosporins. Cephalosporins are bactericidal agents that inhibit bacterial cell wall synthesis by binding to and disrupting the function of penicillin-binding proteins (PBPs).

Cefoxitin has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including many strains that are resistant to other antibiotics. It is commonly used to treat infections caused by susceptible organisms such as:

* Staphylococcus aureus (including methicillin-resistant S. aureus or MRSA)
* Streptococcus pneumoniae
* Escherichia coli
* Klebsiella spp.
* Proteus mirabilis
* Bacteroides fragilis and other anaerobic bacteria

Cefoxitin is available in both intravenous (IV) and intramuscular (IM) formulations, and it is typically administered every 6 to 8 hours. The drug is generally well tolerated, but potential side effects include gastrointestinal symptoms such as diarrhea, nausea, and vomiting, as well as allergic reactions, including rash, pruritus, and anaphylaxis.

It's important to note that the use of antibiotics should be based on the results of bacterial cultures and susceptibility testing whenever possible, to ensure appropriate therapy and minimize the development of antibiotic resistance.

"Enterobacter aerogenes" is a species of gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, including in soil, water, and vegetation. In medical contexts, E. aerogenes is often considered an opportunistic pathogen, meaning it can cause infection in individuals with compromised immune systems or underlying health conditions.

E. aerogenes is a member of the family Enterobacteriaceae and is closely related to other pathogens such as Klebsiella pneumoniae and Escherichia coli. It is known for its ability to produce large amounts of gas, including carbon dioxide and hydrogen sulfide, which can contribute to its virulence and make it difficult to identify using traditional biochemical tests.

E. aerogenes can cause a variety of infections, including urinary tract infections, pneumonia, bacteremia, and wound infections. It is often resistant to multiple antibiotics, which can make treatment challenging. In recent years, there has been an increase in the number of E. aerogenes isolates that are resistant to carbapenems, a class of antibiotics that are often used as a last resort for treating serious bacterial infections.

Proteus mirabilis is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, particularly in soil and water. In humans, P. mirabilis can be part of the normal gut flora but can also cause opportunistic infections, particularly in the urinary tract. It is known for its ability to produce urease, which can lead to the formation of urinary stones and blockages.

P. mirabilis infections are often associated with underlying medical conditions such as diabetes, kidney disease, or urinary catheterization. Symptoms of a P. mirabilis infection may include fever, cloudy or foul-smelling urine, and pain or burning during urination. Treatment typically involves antibiotics that are effective against Gram-negative bacteria, although resistance to certain antibiotics is not uncommon in P. mirabilis isolates.

Isoelectric focusing (IEF) is a technique used in electrophoresis, which is a method for separating proteins or other molecules based on their electrical charges. In IEF, a mixture of ampholytes (molecules that can carry both positive and negative charges) is used to create a pH gradient within a gel matrix. When an electric field is applied, the proteins or molecules migrate through the gel until they reach the point in the gradient where their net charge is zero, known as their isoelectric point (pI). At this point, they focus into a sharp band and stop moving, resulting in a highly resolved separation of the different components based on their pI. This technique is widely used in protein research for applications such as protein identification, characterization, and purification.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Bacterial infections are caused by the invasion and multiplication of bacteria in or on tissues of the body. These infections can range from mild, like a common cold, to severe, such as pneumonia, meningitis, or sepsis. The symptoms of a bacterial infection depend on the type of bacteria invading the body and the area of the body that is affected.

Bacteria are single-celled microorganisms that can live in many different environments, including in the human body. While some bacteria are beneficial to humans and help with digestion or protect against harmful pathogens, others can cause illness and disease. When bacteria invade the body, they can release toxins and other harmful substances that damage tissues and trigger an immune response.

Bacterial infections can be treated with antibiotics, which work by killing or inhibiting the growth of bacteria. However, it is important to note that misuse or overuse of antibiotics can lead to antibiotic resistance, making treatment more difficult. It is also essential to complete the full course of antibiotics as prescribed, even if symptoms improve, to ensure that all bacteria are eliminated and reduce the risk of recurrence or development of antibiotic resistance.

Serotyping is a laboratory technique used to classify microorganisms, such as bacteria and viruses, based on the specific antigens or proteins present on their surface. It involves treating the microorganism with different types of antibodies and observing which ones bind to its surface. Each distinct set of antigens corresponds to a specific serotype, allowing for precise identification and characterization of the microorganism. This technique is particularly useful in epidemiology, vaccine development, and infection control.

Fluoroquinolones are a class of antibiotics that are widely used to treat various types of bacterial infections. They work by interfering with the bacteria's ability to replicate its DNA, which ultimately leads to the death of the bacterial cells. Fluoroquinolones are known for their broad-spectrum activity against both gram-positive and gram-negative bacteria.

Some common fluoroquinolones include ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin. These antibiotics are often used to treat respiratory infections, urinary tract infections, skin infections, and gastrointestinal infections, among others.

While fluoroquinolones are generally well-tolerated, they can cause serious side effects in some people, including tendonitis, nerve damage, and changes in mood or behavior. As with all antibiotics, it's important to use fluoroquinolones only when necessary and under the guidance of a healthcare provider.

Quinolones are a class of antibacterial agents that are widely used in medicine to treat various types of infections caused by susceptible bacteria. These synthetic drugs contain a chemical structure related to quinoline and have broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Quinolones work by inhibiting the bacterial DNA gyrase or topoisomerase IV enzymes, which are essential for bacterial DNA replication, transcription, and repair.

The first quinolone antibiotic was nalidixic acid, discovered in 1962. Since then, several generations of quinolones have been developed, with each generation having improved antibacterial activity and a broader spectrum of action compared to the previous one. The various generations of quinolones include:

1. First-generation quinolones (e.g., nalidixic acid): Primarily used for treating urinary tract infections caused by Gram-negative bacteria.
2. Second-generation quinolones (e.g., ciprofloxacin, ofloxacin, norfloxacin): These drugs have improved activity against both Gram-positive and Gram-negative bacteria and are used to treat a wider range of infections, including respiratory, gastrointestinal, and skin infections.
3. Third-generation quinolones (e.g., levofloxacin, sparfloxacin, grepafloxacin): These drugs have enhanced activity against Gram-positive bacteria, including some anaerobes and atypical organisms like Legionella and Mycoplasma species.
4. Fourth-generation quinolones (e.g., moxifloxacin, gatifloxacin): These drugs have the broadest spectrum of activity, including enhanced activity against Gram-positive bacteria, anaerobes, and some methicillin-resistant Staphylococcus aureus (MRSA) strains.

Quinolones are generally well-tolerated, but like all medications, they can have side effects. Common adverse reactions include gastrointestinal symptoms (nausea, vomiting, diarrhea), headache, and dizziness. Serious side effects, such as tendinitis, tendon rupture, peripheral neuropathy, and QT interval prolongation, are less common but can occur, particularly in older patients or those with underlying medical conditions. The use of quinolones should be avoided or used cautiously in these populations.

Quinolone resistance has become an increasing concern due to the widespread use of these antibiotics. Bacteria can develop resistance through various mechanisms, including chromosomal mutations and the acquisition of plasmid-mediated quinolone resistance genes. The overuse and misuse of quinolones contribute to the emergence and spread of resistant strains, which can limit treatment options for severe infections caused by these bacteria. Therefore, it is essential to use quinolones judiciously and only when clinically indicated, to help preserve their effectiveness and prevent further resistance development.

Penicillanic acid is not a term that has a widely accepted or established medical definition in the context of human medicine or clinical practice. It is a chemical compound that is a derivative of penicillin, an antibiotic produced by certain types of mold. Penicillanic acid is a breakdown product of penicillin and is not itself used as a medication.

In chemistry, penicillanic acid is a organic compound with the formula (CH3)2C6H5COOH. It is a derivative of benzene and has a carboxylic acid group and a five-membered ring containing a sulfur atom and a double bond, which is a characteristic feature of penicillin and its derivatives.

It's important to note that while penicillanic acid may have relevance in the context of chemistry or microbiology research, it does not have a direct medical definition or application in clinical medicine.

Gram-positive bacteria are a type of bacteria that stain dark purple or blue when subjected to the Gram staining method, which is a common technique used in microbiology to classify and identify different types of bacteria based on their structural differences. This staining method was developed by Hans Christian Gram in 1884.

The key characteristic that distinguishes Gram-positive bacteria from other types, such as Gram-negative bacteria, is the presence of a thick layer of peptidoglycan in their cell walls, which retains the crystal violet stain used in the Gram staining process. Additionally, Gram-positive bacteria lack an outer membrane found in Gram-negative bacteria.

Examples of Gram-positive bacteria include Staphylococcus aureus, Streptococcus pyogenes, and Bacillus subtilis. Some Gram-positive bacteria can cause various human diseases, while others are beneficial or harmless.

Bacteria are single-celled microorganisms that are among the earliest known life forms on Earth. They are typically characterized as having a cell wall and no membrane-bound organelles. The majority of bacteria have a prokaryotic organization, meaning they lack a nucleus and other membrane-bound organelles.

Bacteria exist in diverse environments and can be found in every habitat on Earth, including soil, water, and the bodies of plants and animals. Some bacteria are beneficial to their hosts, while others can cause disease. Beneficial bacteria play important roles in processes such as digestion, nitrogen fixation, and biogeochemical cycling.

Bacteria reproduce asexually through binary fission or budding, and some species can also exchange genetic material through conjugation. They have a wide range of metabolic capabilities, with many using organic compounds as their source of energy, while others are capable of photosynthesis or chemosynthesis.

Bacteria are highly adaptable and can evolve rapidly in response to environmental changes. This has led to the development of antibiotic resistance in some species, which poses a significant public health challenge. Understanding the biology and behavior of bacteria is essential for developing strategies to prevent and treat bacterial infections and diseases.

Molecular typing is a laboratory technique used to identify and characterize specific microorganisms, such as bacteria or viruses, at the molecular level. This method is used to differentiate between strains of the same species based on their genetic or molecular differences. Molecular typing techniques include methods such as pulsed-field gel electrophoresis (PFGE), multiple-locus variable number tandem repeat analysis (MLVA), and whole genome sequencing (WGS). These techniques allow for high-resolution discrimination between strains, enabling epidemiological investigations of outbreaks, tracking the transmission of pathogens, and studying the evolution and population biology of microorganisms.

Ciprofloxacin is a fluoroquinolone antibiotic that is used to treat various types of bacterial infections, including respiratory, urinary, and skin infections. It works by inhibiting the bacterial DNA gyrase, which is an enzyme necessary for bacterial replication and transcription. This leads to bacterial cell death. Ciprofloxacin is available in oral and injectable forms and is usually prescribed to be taken twice a day. Common side effects include nausea, diarrhea, and headache. It may also cause serious adverse reactions such as tendinitis, tendon rupture, peripheral neuropathy, and central nervous system effects. It is important to note that ciprofloxacin should not be used in patients with a history of hypersensitivity to fluoroquinolones and should be used with caution in patients with a history of seizures, brain injury, or other neurological conditions.

Penicillin resistance is the ability of certain bacteria to withstand the antibacterial effects of penicillin, a type of antibiotic. This occurs when these bacteria have developed mechanisms that prevent penicillin from binding to and inhibiting the function of their cell wall biosynthesis proteins, particularly the enzyme transpeptidase.

One common mechanism of penicillin resistance is the production of beta-lactamases, enzymes that can hydrolyze and inactivate the beta-lactam ring structure present in penicillin and other related antibiotics. Another mechanism involves alterations in the bacterial cell wall that prevent penicillin from binding to its target proteins.

Penicillin resistance is a significant concern in clinical settings, as it can limit treatment options for bacterial infections and may necessitate the use of more potent or toxic antibiotics. It is important to note that misuse or overuse of antibiotics can contribute to the development and spread of antibiotic-resistant bacteria, including those resistant to penicillin.

Piperacillin is a type of antibiotic known as a semisynthetic penicillin that is used to treat a variety of infections caused by bacteria. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die.

Piperacillin has a broad spectrum of activity against both gram-positive and gram-negative bacteria, including many strains that are resistant to other antibiotics. It is often used in combination with other antibiotics, such as tazobactam, to increase its effectiveness against certain types of bacteria.

Piperacillin is typically administered intravenously in a hospital setting and is used to treat serious infections such as pneumonia, sepsis, and abdominal or urinary tract infections. As with all antibiotics, it should be used only when necessary and under the guidance of a healthcare professional to reduce the risk of antibiotic resistance.

Bacterial antibodies are a type of antibodies produced by the immune system in response to an infection caused by bacteria. These antibodies are proteins that recognize and bind to specific antigens on the surface of the bacterial cells, marking them for destruction by other immune cells. Bacterial antibodies can be classified into several types based on their structure and function, including IgG, IgM, IgA, and IgE. They play a crucial role in the body's defense against bacterial infections and provide immunity to future infections with the same bacteria.

Porins are a type of protein found in the outer membrane of gram-negative bacteria. They form water-filled channels, or pores, that allow small molecules such as ions, nutrients, and waste products to pass through the otherwise impermeable outer membrane. Porins are important for the survival of gram-negative bacteria, as they enable the selective transport of essential molecules while providing a barrier against harmful substances.

There are different types of porins, classified based on their structure and function. Some examples include:

1. General porins (also known as nonspecific porins): These are the most common type of porins and form large, water-filled channels that allow passive diffusion of small molecules up to 600-700 Da in size. They typically have a trimeric structure, with three identical or similar subunits forming a pore in the membrane.
2. Specific porins: These porins are more selective in the molecules they allow to pass through and often have smaller pores than general porins. They can be involved in the active transport of specific molecules or ions, requiring energy from the cell.
3. Autotransporters: While not strictly considered porins, autotransporter proteins share some structural similarities with porins and are involved in the transport of protein domains across the outer membrane. They consist of an N-terminal passenger domain and a C-terminal translocator domain, which forms a β-barrel pore in the outer membrane through which the passenger domain is transported.

Porins have attracted interest as potential targets for antibiotic development, as they play crucial roles in bacterial survival and virulence. Inhibiting porin function or blocking the pores could disrupt essential processes in gram-negative bacteria, providing a new approach to treating infections caused by these organisms.

I'm sorry for any confusion, but "Greece" is not a medical term or concept. Greece is a country located in southeastern Europe, known for its rich history, culture, and contributions to various fields including philosophy, politics, arts, and sciences. If you have any questions related to medical topics or definitions, I'd be happy to help.

A "colony count" is a method used to estimate the number of viable microorganisms, such as bacteria or fungi, in a sample. In this technique, a known volume of the sample is spread onto the surface of a solid nutrient medium in a petri dish and then incubated under conditions that allow the microorganisms to grow and form visible colonies. Each colony that grows on the plate represents an individual cell (or small cluster of cells) from the original sample that was able to divide and grow under the given conditions. By counting the number of colonies that form, researchers can make a rough estimate of the concentration of microorganisms in the original sample.

The term "microbial" simply refers to microscopic organisms, such as bacteria, fungi, or viruses. Therefore, a "colony count, microbial" is a general term that encompasses the use of colony counting techniques to estimate the number of any type of microorganism in a sample.

Colony counts are used in various fields, including medical research, food safety testing, and environmental monitoring, to assess the levels of contamination or the effectiveness of disinfection procedures. However, it is important to note that colony counts may not always provide an accurate measure of the total number of microorganisms present in a sample, as some cells may be injured or unable to grow under the conditions used for counting. Additionally, some microorganisms may form clusters or chains that can appear as single colonies, leading to an overestimation of the true cell count.

Penicillins are a group of antibiotics derived from the Penicillium fungus. They are widely used to treat various bacterial infections due to their bactericidal activity, which means they kill bacteria by interfering with the synthesis of their cell walls. The first penicillin, benzylpenicillin (also known as penicillin G), was discovered in 1928 by Sir Alexander Fleming. Since then, numerous semi-synthetic penicillins have been developed to expand the spectrum of activity and stability against bacterial enzymes that can inactivate these drugs.

Penicillins are classified into several groups based on their chemical structure and spectrum of activity:

1. Natural Penicillins (e.g., benzylpenicillin, phenoxymethylpenicillin): These have a narrow spectrum of activity, mainly targeting Gram-positive bacteria such as streptococci and staphylococci. However, they are susceptible to degradation by beta-lactamase enzymes produced by some bacteria.
2. Penicillinase-resistant Penicillins (e.g., methicillin, oxacillin, nafcillin): These penicillins resist degradation by certain bacterial beta-lactamases and are primarily used to treat infections caused by staphylococci, including methicillin-susceptible Staphylococcus aureus (MSSA).
3. Aminopenicillins (e.g., ampicillin, amoxicillin): These penicillins have an extended spectrum of activity compared to natural penicillins, including some Gram-negative bacteria such as Escherichia coli and Haemophilus influenzae. However, they are still susceptible to degradation by many beta-lactamases.
4. Antipseudomonal Penicillins (e.g., carbenicillin, ticarcillin): These penicillins have activity against Pseudomonas aeruginosa and other Gram-negative bacteria with increased resistance to other antibiotics. They are often combined with beta-lactamase inhibitors such as clavulanate or tazobactam to protect them from degradation.
5. Extended-spectrum Penicillins (e.g., piperacillin): These penicillins have a broad spectrum of activity, including many Gram-positive and Gram-negative bacteria. They are often combined with beta-lactamase inhibitors to protect them from degradation.

Penicillins are generally well-tolerated antibiotics; however, they can cause allergic reactions in some individuals, ranging from mild skin rashes to life-threatening anaphylaxis. Cross-reactivity between different penicillin classes and other beta-lactam antibiotics (e.g., cephalosporins) is possible but varies depending on the specific drugs involved.

"Pseudomonas aeruginosa" is a medically important, gram-negative, rod-shaped bacterium that is widely found in the environment, such as in soil, water, and on plants. It's an opportunistic pathogen, meaning it usually doesn't cause infection in healthy individuals but can cause severe and sometimes life-threatening infections in people with weakened immune systems, burns, or chronic lung diseases like cystic fibrosis.

P. aeruginosa is known for its remarkable ability to resist many antibiotics and disinfectants due to its intrinsic resistance mechanisms and the acquisition of additional resistance determinants. It can cause various types of infections, including respiratory tract infections, urinary tract infections, gastrointestinal infections, dermatitis, and severe bloodstream infections known as sepsis.

The bacterium produces a variety of virulence factors that contribute to its pathogenicity, such as exotoxins, proteases, and pigments like pyocyanin and pyoverdine, which aid in iron acquisition and help the organism evade host immune responses. Effective infection control measures, appropriate use of antibiotics, and close monitoring of high-risk patients are crucial for managing P. aeruginosa infections.

Gene expression regulation in bacteria refers to the complex cellular processes that control the production of proteins from specific genes. This regulation allows bacteria to adapt to changing environmental conditions and ensure the appropriate amount of protein is produced at the right time.

Bacteria have a variety of mechanisms for regulating gene expression, including:

1. Operon structure: Many bacterial genes are organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule. The expression of these genes can be coordinately regulated by controlling the transcription of the entire operon.
2. Promoter regulation: Transcription is initiated at promoter regions upstream of the gene or operon. Bacteria have regulatory proteins called sigma factors that bind to the promoter and recruit RNA polymerase, the enzyme responsible for transcribing DNA into RNA. The binding of sigma factors can be influenced by environmental signals, allowing for regulation of transcription.
3. Attenuation: Some operons have regulatory regions called attenuators that control transcription termination. These regions contain hairpin structures that can form in the mRNA and cause transcription to stop prematurely. The formation of these hairpins is influenced by the concentration of specific metabolites, allowing for regulation of gene expression based on the availability of those metabolites.
4. Riboswitches: Some bacterial mRNAs contain regulatory elements called riboswitches that bind small molecules directly. When a small molecule binds to the riboswitch, it changes conformation and affects transcription or translation of the associated gene.
5. CRISPR-Cas systems: Bacteria use CRISPR-Cas systems for adaptive immunity against viruses and plasmids. These systems incorporate short sequences from foreign DNA into their own genome, which can then be used to recognize and cleave similar sequences in invading genetic elements.

Overall, gene expression regulation in bacteria is a complex process that allows them to respond quickly and efficiently to changing environmental conditions. Understanding these regulatory mechanisms can provide insights into bacterial physiology and help inform strategies for controlling bacterial growth and behavior.

A disease outbreak is defined as the occurrence of cases of a disease in excess of what would normally be expected in a given time and place. It may affect a small and localized group or a large number of people spread over a wide area, even internationally. An outbreak may be caused by a new agent, a change in the agent's virulence or host susceptibility, or an increase in the size or density of the host population.

Outbreaks can have significant public health and economic impacts, and require prompt investigation and control measures to prevent further spread of the disease. The investigation typically involves identifying the source of the outbreak, determining the mode of transmission, and implementing measures to interrupt the chain of infection. This may include vaccination, isolation or quarantine, and education of the public about the risks and prevention strategies.

Examples of disease outbreaks include foodborne illnesses linked to contaminated food or water, respiratory infections spread through coughing and sneezing, and mosquito-borne diseases such as Zika virus and West Nile virus. Outbreaks can also occur in healthcare settings, such as hospitals and nursing homes, where vulnerable populations may be at increased risk of infection.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

'Azotobacter' is a genus of free-living nitrogen-fixing bacteria commonly found in soil and water. These bacteria are capable of converting atmospheric nitrogen into ammonia, a process known as nitrogen fixation, which can then be used by plants for growth. The name 'Azotobacter' comes from the Greek words "azoto," meaning without life, and "bakterion," meaning little rod.

The bacteria are characterized by their ability to form cysts or thick-walled resting stages that allow them to survive in unfavorable conditions such as dryness or high temperatures. They are also known for their large size, typically ranging from 1.5 to 2.5 micrometers in diameter, and their motility, which is powered by a single polar flagellum.

'Azotobacter' species are important contributors to the nitrogen cycle in soil and play a crucial role in maintaining soil fertility. They have also been studied for their potential use in various industrial applications, such as the production of biofuels, bioplastics, and enzymes.

Bacteriological techniques refer to the various methods and procedures used in the laboratory for the cultivation, identification, and study of bacteria. These techniques are essential in fields such as medicine, biotechnology, and research. Here are some common bacteriological techniques:

1. **Sterilization**: This is a process that eliminates or kills all forms of life, including bacteria, viruses, fungi, and spores. Common sterilization methods include autoclaving (using steam under pressure), dry heat (in an oven), chemical sterilants, and radiation.

2. **Aseptic Technique**: This refers to practices used to prevent contamination of sterile materials or environments with microorganisms. It includes the use of sterile equipment, gloves, and lab coats, as well as techniques such as flaming, alcohol swabbing, and using aseptic transfer devices.

3. **Media Preparation**: This involves the preparation of nutrient-rich substances that support bacterial growth. There are various types of media, including solid (agar), liquid (broth), and semi-solid (e.g., stab agar). The choice of medium depends on the type of bacteria being cultured and the purpose of the investigation.

4. **Inoculation**: This is the process of introducing a bacterial culture into a medium. It can be done using a loop, swab, or needle. The inoculum should be taken from a pure culture to avoid contamination.

5. **Incubation**: After inoculation, the bacteria are allowed to grow under controlled conditions of temperature, humidity, and atmospheric composition. This process is called incubation.

6. **Staining and Microscopy**: Bacteria are too small to be seen with the naked eye. Therefore, they need to be stained and observed under a microscope. Gram staining is a common method used to differentiate between two major groups of bacteria based on their cell wall composition.

7. **Biochemical Tests**: These are tests used to identify specific bacterial species based on their biochemical characteristics, such as their ability to ferment certain sugars, produce particular enzymes, or resist certain antibiotics.

8. **Molecular Techniques**: Advanced techniques like PCR and DNA sequencing can provide more precise identification of bacteria. They can also be used for genetic analysis and epidemiological studies.

Remember, handling microorganisms requires careful attention to biosafety procedures to prevent accidental infection or environmental contamination.

Culture media is a substance that is used to support the growth of microorganisms or cells in an artificial environment, such as a petri dish or test tube. It typically contains nutrients and other factors that are necessary for the growth and survival of the organisms being cultured. There are many different types of culture media, each with its own specific formulation and intended use. Some common examples include blood agar, which is used to culture bacteria; Sabouraud dextrose agar, which is used to culture fungi; and Eagle's minimum essential medium, which is used to culture animal cells.

Aztreonam is a monobactam antibiotic, which is a type of antibacterial drug used to treat infections caused by bacteria. It works by interfering with the ability of bacterial cells to form cell walls, leading to their death. Aztreonam is specifically active against certain types of gram-negative bacteria, including Pseudomonas aeruginosa and Escherichia coli.

Aztreonam is available in various forms, including injectable solutions and inhaled powder, for use in different clinical settings. It is often used to treat serious infections that have not responded to other antibiotics or that are caused by bacteria that are resistant to other antibiotics.

Like all antibiotics, aztreonam can cause side effects, including nausea, vomiting, diarrhea, and headache. It may also cause allergic reactions in some people, particularly those with a history of allergies to other antibiotics. It is important to use aztreonam only as directed by a healthcare provider and to report any unusual symptoms or side effects promptly.

An operon is a genetic unit in prokaryotic organisms (like bacteria) consisting of a cluster of genes that are transcribed together as a single mRNA molecule, which then undergoes translation to produce multiple proteins. This genetic organization allows for the coordinated regulation of genes that are involved in the same metabolic pathway or functional process. The unit typically includes promoter and operator regions that control the transcription of the operon, as well as structural genes encoding the proteins. Operons were first discovered in bacteria, but similar genetic organizations have been found in some eukaryotic organisms, such as yeast.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Molecular epidemiology is a branch of epidemiology that uses laboratory techniques to identify and analyze the genetic material (DNA, RNA) of pathogens or host cells to understand their distribution, transmission, and disease associations in populations. It combines molecular biology methods with epidemiological approaches to investigate the role of genetic factors in disease occurrence and outcomes. This field has contributed significantly to the identification of infectious disease outbreaks, tracking the spread of antibiotic-resistant bacteria, understanding the transmission dynamics of viruses, and identifying susceptible populations for targeted interventions.

Bacterial typing techniques are methods used to identify and differentiate bacterial strains or isolates based on their unique characteristics. These techniques are essential in epidemiological studies, infection control, and research to understand the transmission dynamics, virulence, and antibiotic resistance patterns of bacterial pathogens.

There are various bacterial typing techniques available, including:

1. **Bacteriophage Typing:** This method involves using bacteriophages (viruses that infect bacteria) to identify specific bacterial strains based on their susceptibility or resistance to particular phages.
2. **Serotyping:** It is a technique that differentiates bacterial strains based on the antigenic properties of their cell surface components, such as capsules, flagella, and somatic (O) and flagellar (H) antigens.
3. **Biochemical Testing:** This method uses biochemical reactions to identify specific metabolic pathways or enzymes present in bacterial strains, which can be used for differentiation. Commonly used tests include the catalase test, oxidase test, and various sugar fermentation tests.
4. **Molecular Typing Techniques:** These methods use genetic markers to identify and differentiate bacterial strains at the DNA level. Examples of molecular typing techniques include:
* **Pulsed-Field Gel Electrophoresis (PFGE):** This method uses restriction enzymes to digest bacterial DNA, followed by electrophoresis in an agarose gel under pulsed electrical fields. The resulting banding patterns are analyzed and compared to identify related strains.
* **Multilocus Sequence Typing (MLST):** It involves sequencing specific housekeeping genes to generate unique sequence types that can be used for strain identification and phylogenetic analysis.
* **Whole Genome Sequencing (WGS):** This method sequences the entire genome of a bacterial strain, providing the most detailed information on genetic variation and relatedness between strains. WGS data can be analyzed using various bioinformatics tools to identify single nucleotide polymorphisms (SNPs), gene deletions or insertions, and other genetic changes that can be used for strain differentiation.

These molecular typing techniques provide higher resolution than traditional methods, allowing for more accurate identification and comparison of bacterial strains. They are particularly useful in epidemiological investigations to track the spread of pathogens and identify outbreaks.

Disk diffusion antimicrobial susceptibility tests, also known as Kirby-Bauer tests, are laboratory methods used to determine the effectiveness of antibiotics against a specific bacterial strain. This test provides a simple and standardized way to estimate the susceptibility or resistance of a microorganism to various antibiotics.

In this method, a standardized inoculum of the bacterial suspension is spread evenly on the surface of an agar plate. Antibiotic-impregnated paper disks are then placed on the agar surface, allowing the diffusion of the antibiotic into the agar. After incubation, the zone of inhibition surrounding each disk is measured. The size of the zone of inhibition correlates with the susceptibility or resistance of the bacterial strain to that specific antibiotic.

The results are interpreted based on predefined criteria established by organizations such as the Clinical and Laboratory Standards Institute (CLSI) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST). These interpretive criteria help categorize the susceptibility of the bacterial strain into one of three categories: susceptible, intermediate, or resistant.

It is important to note that disk diffusion tests have limitations and may not always accurately predict clinical outcomes. However, they remain a valuable tool in guiding empirical antibiotic therapy and monitoring antimicrobial resistance trends.

Urinary Tract Infections (UTIs) are defined as the presence of pathogenic microorganisms, typically bacteria, in any part of the urinary system, which includes the kidneys, ureters, bladder, and urethra, resulting in infection and inflammation. The majority of UTIs are caused by Escherichia coli (E. coli) bacteria, but other organisms such as Klebsiella, Proteus, Staphylococcus saprophyticus, and Enterococcus can also cause UTIs.

UTIs can be classified into two types based on the location of the infection:

1. Lower UTI or bladder infection (cystitis): This type of UTI affects the bladder and urethra. Symptoms may include a frequent and urgent need to urinate, pain or burning during urination, cloudy or strong-smelling urine, and discomfort in the lower abdomen or back.

2. Upper UTI or kidney infection (pyelonephritis): This type of UTI affects the kidneys and can be more severe than a bladder infection. Symptoms may include fever, chills, nausea, vomiting, and pain in the flanks or back.

UTIs are more common in women than men due to their shorter urethra, which makes it easier for bacteria to reach the bladder. Other risk factors for UTIs include sexual activity, use of diaphragms or spermicides, urinary catheterization, diabetes, and weakened immune systems.

UTIs are typically diagnosed through a urinalysis and urine culture to identify the causative organism and determine the appropriate antibiotic treatment. In some cases, imaging studies such as ultrasound or CT scan may be necessary to evaluate for any underlying abnormalities in the urinary tract.

Clavulanic acid is a type of beta-lactamase inhibitor, which is a compound that is used to increase the effectiveness of certain antibiotics. It works by preventing the breakdown of beta-lactam antibiotics (such as penicillins and cephalosporins) by bacterial enzymes called beta-lactamases. This allows the antibiotic to remain active against the bacteria for a longer period of time, increasing its ability to kill the bacteria and treat the infection.

Clavulanic acid is often combined with amoxicillin in a medication called Augmentin, which is used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It may also be used in other combinations with other beta-lactam antibiotics.

Like all medications, clavulanic acid can have side effects, including gastrointestinal symptoms such as diarrhea, nausea, and vomiting. It may also cause allergic reactions in some people, particularly those who are allergic to penicillin or other beta-lactam antibiotics. It is important to follow the instructions of a healthcare provider when taking clavulanic acid or any medication.

Molecular cloning is a laboratory technique used to create multiple copies of a specific DNA sequence. This process involves several steps:

1. Isolation: The first step in molecular cloning is to isolate the DNA sequence of interest from the rest of the genomic DNA. This can be done using various methods such as PCR (polymerase chain reaction), restriction enzymes, or hybridization.
2. Vector construction: Once the DNA sequence of interest has been isolated, it must be inserted into a vector, which is a small circular DNA molecule that can replicate independently in a host cell. Common vectors used in molecular cloning include plasmids and phages.
3. Transformation: The constructed vector is then introduced into a host cell, usually a bacterial or yeast cell, through a process called transformation. This can be done using various methods such as electroporation or chemical transformation.
4. Selection: After transformation, the host cells are grown in selective media that allow only those cells containing the vector to grow. This ensures that the DNA sequence of interest has been successfully cloned into the vector.
5. Amplification: Once the host cells have been selected, they can be grown in large quantities to amplify the number of copies of the cloned DNA sequence.

Molecular cloning is a powerful tool in molecular biology and has numerous applications, including the production of recombinant proteins, gene therapy, functional analysis of genes, and genetic engineering.

DNA fingerprinting, also known as DNA profiling or genetic fingerprinting, is a laboratory technique used to identify and compare the unique genetic makeup of individuals by analyzing specific regions of their DNA. This method is based on the variation in the length of repetitive sequences of DNA called variable number tandem repeats (VNTRs) or short tandem repeats (STRs), which are located at specific locations in the human genome and differ significantly among individuals, except in the case of identical twins.

The process of DNA fingerprinting involves extracting DNA from a sample, amplifying targeted regions using the polymerase chain reaction (PCR), and then separating and visualizing the resulting DNA fragments through electrophoresis. The fragment patterns are then compared to determine the likelihood of a match between two samples.

DNA fingerprinting has numerous applications in forensic science, paternity testing, identity verification, and genealogical research. It is considered an essential tool for providing strong evidence in criminal investigations and resolving disputes related to parentage and inheritance.

"O antigens" are a type of antigen found on the lipopolysaccharide (LPS) component of the outer membrane of Gram-negative bacteria. The "O" in O antigens stands for "outer" membrane. These antigens are composed of complex carbohydrates and can vary between different strains of the same species of bacteria, which is why they are also referred to as the bacterial "O" somatic antigens.

The O antigens play a crucial role in the virulence and pathogenesis of many Gram-negative bacteria, as they help the bacteria evade the host's immune system by changing the structure of the O antigen, making it difficult for the host to mount an effective immune response against the bacterial infection.

The identification and classification of O antigens are important in epidemiology, clinical microbiology, and vaccine development, as they can be used to differentiate between different strains of bacteria and to develop vaccines that provide protection against specific bacterial infections.

Propanediol Dehydratase is not a medical term per se, but rather a biochemical term. It refers to an enzyme that catalyzes the conversion of 1,2-propanediol (also known as propylene glycol) into propionaldehyde and water in the metabolic pathway known as the glycerol/propanediol utilization (GUD) system.

The reaction catalyzed by Propanediol Dehydratase is:
(CH3)2CH(OH)CH2OH → CH3CH2CHO + H2O

This enzyme is found in certain bacteria and archaea that are capable of utilizing 1,2-propanediol as a carbon source for growth. Deficiency or absence of this enzyme can affect the metabolic capabilities of these microorganisms.

"Serratia marcescens" is a medically significant species of gram-negative, facultatively anaerobic, motile bacillus bacteria that belongs to the family Enterobacteriaceae. It is commonly found in soil, water, and in the gastrointestinal tracts of humans and animals. The bacteria are known for their ability to produce a red pigment called prodigiosin, which gives them a distinctive pink color on many types of laboratory media.

"Serratia marcescens" can cause various types of infections, including respiratory tract infections, urinary tract infections, wound infections, and bacteremia (bloodstream infections). It is also known to be an opportunistic pathogen, which means that it primarily causes infections in individuals with weakened immune systems, such as those with chronic illnesses or who are undergoing medical treatments that suppress the immune system.

In healthcare settings, "Serratia marcescens" can cause outbreaks of infection, particularly in patients who are hospitalized for extended periods of time. It is resistant to many commonly used antibiotics, which makes it difficult to treat and control the spread of infections caused by this organism.

In addition to its medical significance, "Serratia marcescens" has also been used as a model organism in various areas of microbiological research, including studies on bacterial motility, biofilm formation, and antibiotic resistance.

Community-acquired infections are those that are acquired outside of a healthcare setting, such as in one's own home or community. These infections are typically contracted through close contact with an infected person, contaminated food or water, or animals. Examples of community-acquired infections include the common cold, flu, strep throat, and many types of viral and bacterial gastrointestinal infections.

These infections are different from healthcare-associated infections (HAIs), which are infections that patients acquire while they are receiving treatment for another condition in a healthcare setting, such as a hospital or long-term care facility. HAIs can be caused by a variety of factors, including contact with contaminated surfaces or equipment, invasive medical procedures, and the use of certain medications.

It is important to note that community-acquired infections can also occur in healthcare settings if proper infection control measures are not in place. Healthcare providers must take steps to prevent the spread of these infections, such as washing their hands regularly, using personal protective equipment (PPE), and implementing isolation precautions for patients with known or suspected infectious diseases.

Bacterial fimbriae are thin, hair-like protein appendages that extend from the surface of many types of bacteria. They are involved in the attachment of bacteria to surfaces, other cells, or extracellular structures. Fimbriae enable bacteria to adhere to host tissues and form biofilms, which contribute to bacterial pathogenicity and survival in various environments. These protein structures are composed of several thousand subunits of a specific protein called pilin. Some fimbriae can recognize and bind to specific receptors on host cells, initiating the process of infection and colonization.

Bacterial transformation is a natural process by which exogenous DNA is taken up and incorporated into the genome of a bacterial cell. This process was first discovered in 1928 by Frederick Griffith, who observed that dead virulent bacteria could transfer genetic material to live avirulent bacteria, thereby conferring new properties such as virulence to the recipient cells.

The uptake of DNA by bacterial cells typically occurs through a process called "competence," which can be either naturally induced under certain environmental conditions or artificially induced in the laboratory using various methods. Once inside the cell, the exogenous DNA may undergo recombination with the host genome, resulting in the acquisition of new genes or the alteration of existing ones.

Bacterial transformation has important implications for both basic research and biotechnology. It is a powerful tool for studying gene function and for engineering bacteria with novel properties, such as the ability to produce valuable proteins or degrade environmental pollutants. However, it also poses potential risks in the context of genetic engineering and biocontainment, as transformed bacteria may be able to transfer their newly acquired genes to other organisms in the environment.

The nasopharynx is the uppermost part of the pharynx (throat), which is located behind the nose. It is a muscular cavity that serves as a passageway for air and food. The nasopharynx extends from the base of the skull to the lower border of the soft palate, where it continues as the oropharynx. Its primary function is to allow air to flow into the respiratory system through the nostrils while also facilitating the drainage of mucus from the nose into the throat. The nasopharynx contains several important structures, including the adenoids and the opening of the Eustachian tubes, which connect the middle ear to the back of the nasopharynx.

Bacterial outer membrane proteins (OMPs) are a type of protein found in the outer membrane of gram-negative bacteria. The outer membrane is a unique characteristic of gram-negative bacteria, and it serves as a barrier that helps protect the bacterium from hostile environments. OMPs play a crucial role in maintaining the structural integrity and selective permeability of the outer membrane. They are involved in various functions such as nutrient uptake, transport, adhesion, and virulence factor secretion.

OMPs are typically composed of beta-barrel structures that span the bacterial outer membrane. These proteins can be classified into several groups based on their size, function, and structure. Some of the well-known OMP families include porins, autotransporters, and two-partner secretion systems.

Porins are the most abundant type of OMPs and form water-filled channels that allow the passive diffusion of small molecules, ions, and nutrients across the outer membrane. Autotransporters are a diverse group of OMPs that play a role in bacterial pathogenesis by secreting virulence factors or acting as adhesins. Two-partner secretion systems involve the cooperation between two proteins to transport effector molecules across the outer membrane.

Understanding the structure and function of bacterial OMPs is essential for developing new antibiotics and therapies that target gram-negative bacteria, which are often resistant to conventional treatments.

I'm sorry for any confusion, but "Molybdenum" is not a medical term. It is an element with the symbol Mo and atomic number 42 on the periodic table. Molybdenum is used in various industries, including medicine, for example in the production of surgical instruments and some prosthetics due to its strength and resistance to corrosion. However, it is not a term used to describe a medical condition or bodily process. If you have any questions related to elements and their uses in medicine, I'd be happy to help with those!

Rhinoscleroma is a chronic, granulomatous infection that primarily affects the nasal mucosa. It's caused by the bacterium Klebsiella rhinoscleromatis (formerly named Klebsiella pneumoniae subsp. rhinoscleromatis). The disease is characterized by the formation of firm, woody granulomas that can lead to destruction of the nasal structures and deformity of the nose if left untreated.

The infection typically progresses through three stages: catarrhal, granulomatous, and fibrotic. In the catarrhal stage, there is a persistent runny nose and nasal congestion. The granulomatous stage is characterized by the formation of nodules and plaques in the nasal passages, which can cause crusting, foul-smelling discharge, and difficulty breathing through the nose. In the fibrotic stage, the tissues of the nose become thickened, hardened, and scarred, leading to deformity and loss of function.

Rhinoscleroma is most commonly found in developing countries with poor socioeconomic conditions, particularly in tropical and subtropical regions. It's more prevalent in populations with limited access to healthcare and clean water, as well as those living in overcrowded conditions. The disease primarily affects young adults and children, and it has a slight female predominance.

Treatment for rhinoscleroma typically involves long-term antibiotic therapy using agents such as trimethoprim-sulfamethoxazole, tetracyclines, or fluoroquinolones. In some cases, surgical intervention may be necessary to remove scar tissue and restore nasal function. Preventive measures include improving living conditions, access to clean water, and early detection and treatment of the disease.

'Citrobacter freundii' is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that is commonly found in the environment, including water, soil, and plants. It is also part of the normal gut flora in humans and animals. The bacterium can cause various types of infections in people with weakened immune systems, such as newborns, the elderly, and those with chronic diseases. Infections caused by 'Citrobacter freundii' may include urinary tract infections, pneumonia, bloodstream infections, and wound infections. Proper identification and antibiotic susceptibility testing are crucial for effective treatment of these infections.

Bacterial adhesion is the initial and crucial step in the process of bacterial colonization, where bacteria attach themselves to a surface or tissue. This process involves specific interactions between bacterial adhesins (proteins, fimbriae, or pili) and host receptors (glycoproteins, glycolipids, or extracellular matrix components). The attachment can be either reversible or irreversible, depending on the strength of interaction. Bacterial adhesion is a significant factor in initiating biofilm formation, which can lead to various infectious diseases and medical device-associated infections.

I'm sorry for any confusion, but "Taiwan" is not a medical term or concept. It is the name of an island nation located in East Asia. The official name of the country is the Republic of China (ROC). If you have any medical questions or inquiries, I would be happy to help answer those for you!

Thioglycosides are organic compounds that contain a sulfur atom (sulfur-sulfur bond) linked to a glycosyl group. They are structurally similar to glycosides, but instead of having an oxygen atom linking the sugar moiety to the aglycone, they have a sulfur atom. Thioglycosides are often used in glycobiology research as inhibitors of glycosidases or as substrates for glycosyltransferases. They also have applications in the pharmaceutical industry as anti-microbial and anti-cancer agents.

Ampicillin is a penicillin-type antibiotic used to treat a wide range of bacterial infections. It works by interfering with the ability of bacteria to form cell walls, which are essential for their survival. This causes the bacterial cells to become unstable and eventually die.

The medical definition of Ampicillin is:

"A semi-synthetic penicillin antibiotic, derived from the Penicillium mold. It is used to treat a variety of infections caused by susceptible gram-positive and gram-negative bacteria. Ampicillin is effective against both aerobic and anaerobic organisms. It is commonly used to treat respiratory tract infections, urinary tract infections, meningitis, and endocarditis."

It's important to note that Ampicillin is not effective against infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or other bacteria that have developed resistance to penicillins. Additionally, overuse of antibiotics like Ampicillin can lead to the development of antibiotic resistance, which is a significant public health concern.

Chlamydia infections are caused by the bacterium Chlamydia trachomatis and can affect multiple body sites, including the genitals, eyes, and respiratory system. The most common type of chlamydia infection is a sexually transmitted infection (STI) that affects the genitals.

In women, chlamydia infections can cause symptoms such as abnormal vaginal discharge, burning during urination, and pain in the lower abdomen. In men, symptoms may include discharge from the penis, painful urination, and testicular pain or swelling. However, many people with chlamydia infections do not experience any symptoms at all.

If left untreated, chlamydia infections can lead to serious complications, such as pelvic inflammatory disease (PID) in women, which can cause infertility and ectopic pregnancy. In men, chlamydia infections can cause epididymitis, an inflammation of the tube that carries sperm from the testicles, which can also lead to infertility.

Chlamydia infections are diagnosed through a variety of tests, including urine tests and swabs taken from the affected area. Once diagnosed, chlamydia infections can be treated with antibiotics such as azithromycin or doxycycline. It is important to note that treatment only clears the infection and does not repair any damage caused by the infection.

Prevention measures include practicing safe sex, getting regular STI screenings, and avoiding sharing towels or other personal items that may come into contact with infected bodily fluids.

Virulence, in the context of medicine and microbiology, refers to the degree or severity of damage or harm that a pathogen (like a bacterium, virus, fungus, or parasite) can cause to its host. It is often associated with the ability of the pathogen to invade and damage host tissues, evade or suppress the host's immune response, replicate within the host, and spread between hosts.

Virulence factors are the specific components or mechanisms that contribute to a pathogen's virulence, such as toxins, enzymes, adhesins, and capsules. These factors enable the pathogen to establish an infection, cause tissue damage, and facilitate its transmission between hosts. The overall virulence of a pathogen can be influenced by various factors, including host susceptibility, environmental conditions, and the specific strain or species of the pathogen.

'Proteus' doesn't have a specific medical definition itself, but it is related to a syndrome in medicine. Proteus syndrome is a rare genetic disorder characterized by the overgrowth of various tissues and organs in the body. The name "Proteus" comes from the Greek god Proteus, who could change his form at will, reflecting the diverse and ever-changing nature of this condition's symptoms.

People with Proteus syndrome experience asymmetric overgrowth of bones, skin, and other tissues, leading to abnormalities in body shape and function. The disorder can also affect blood vessels, causing benign tumors called hamartomas to develop. Additionally, individuals with Proteus syndrome are at an increased risk of developing certain types of cancer.

The genetic mutation responsible for Proteus syndrome is found in the AKT1 gene, which plays a crucial role in cell growth and division. This disorder is typically not inherited but instead arises spontaneously as a new mutation in the affected individual. Early diagnosis and management of Proteus syndrome can help improve patients' quality of life and reduce complications associated with the condition.

Cefazolin is a type of antibiotic known as a cephalosporin, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria are not able to grow and multiply, and are eventually destroyed by the body's immune system.

Cefazolin is commonly used to treat infections of the skin, bones, joints, heart, lungs, and urinary tract. It may also be used to prevent infection during surgery. Like all antibiotics, cefazolin is only effective against certain types of bacteria, so it is important to know the specific type of bacteria causing an infection before using this medication.

Cefazolin is usually given as an injection into a vein or muscle, and may be administered in a hospital setting or at home with proper training. The dosage and duration of treatment will depend on the severity and location of the infection, as well as the patient's overall health status.

As with any medication, cefazolin can cause side effects, including diarrhea, nausea, vomiting, headache, and rash. In rare cases, it may also cause serious side effects such as allergic reactions, kidney damage, or abnormal blood clotting. It is important to report any unusual symptoms to a healthcare provider promptly.

It is essential to complete the full course of treatment with cefazolin, even if symptoms improve, to ensure that the infection is fully treated and to reduce the risk of antibiotic resistance.

DNA transposable elements, also known as transposons or jumping genes, are mobile genetic elements that can change their position within a genome. They are composed of DNA sequences that include genes encoding the enzymes required for their own movement (transposase) and regulatory elements. When activated, the transposase recognizes specific sequences at the ends of the element and catalyzes the excision and reintegration of the transposable element into a new location in the genome. This process can lead to genetic variation, as the insertion of a transposable element can disrupt the function of nearby genes or create new combinations of gene regulatory elements. Transposable elements are widespread in both prokaryotic and eukaryotic genomes and are thought to play a significant role in genome evolution.

Aminoglycosides are a class of antibiotics that are derived from bacteria and are used to treat various types of infections caused by gram-negative and some gram-positive bacteria. These antibiotics work by binding to the 30S subunit of the bacterial ribosome, which inhibits protein synthesis and ultimately leads to bacterial cell death.

Some examples of aminoglycosides include gentamicin, tobramycin, neomycin, and streptomycin. These antibiotics are often used in combination with other antibiotics to treat severe infections, such as sepsis, pneumonia, and urinary tract infections.

Aminoglycosides can have serious side effects, including kidney damage and hearing loss, so they are typically reserved for use in serious infections that cannot be treated with other antibiotics. They are also used topically to treat skin infections and prevent wound infections after surgery.

It's important to note that aminoglycosides should only be used under the supervision of a healthcare professional, as improper use can lead to antibiotic resistance and further health complications.

Respiratory tract infections (RTIs) are infections that affect the respiratory system, which includes the nose, throat (pharynx), voice box (larynx), windpipe (trachea), bronchi, and lungs. These infections can be caused by viruses, bacteria, or, less commonly, fungi.

RTIs are classified into two categories based on their location: upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs). URTIs include infections of the nose, sinuses, throat, and larynx, such as the common cold, flu, laryngitis, and sinusitis. LRTIs involve the lower airways, including the bronchi and lungs, and can be more severe. Examples of LRTIs are pneumonia, bronchitis, and bronchiolitis.

Symptoms of RTIs depend on the location and cause of the infection but may include cough, congestion, runny nose, sore throat, difficulty breathing, wheezing, fever, fatigue, and chest pain. Treatment for RTIs varies depending on the severity and underlying cause of the infection. For viral infections, treatment typically involves supportive care to manage symptoms, while antibiotics may be prescribed for bacterial infections.

Species specificity is a term used in the field of biology, including medicine, to refer to the characteristic of a biological entity (such as a virus, bacterium, or other microorganism) that allows it to interact exclusively or preferentially with a particular species. This means that the biological entity has a strong affinity for, or is only able to infect, a specific host species.

For example, HIV is specifically adapted to infect human cells and does not typically infect other animal species. Similarly, some bacterial toxins are species-specific and can only affect certain types of animals or humans. This concept is important in understanding the transmission dynamics and host range of various pathogens, as well as in developing targeted therapies and vaccines.

Integrons are genetic elements that can capture, integrate and express mobile gene cassettes, which are circular DNA molecules containing one or more antibiotic resistance genes. Integrons consist of an integrase gene (intI), a recombination site (attI), and a promoter region that drives the expression of integrated gene cassettes. They play a significant role in the spread and dissemination of antibiotic resistance among bacterial populations, as they can facilitate the acquisition and exchange of resistance genes between different bacteria. Integrons are commonly found on plasmids and transposons, which are mobile genetic elements that can move between different bacterial species, further contributing to the rapid spread of antibiotic resistance.

A "University Hospital" is a type of hospital that is often affiliated with a medical school or university. These hospitals serve as major teaching institutions where medical students, residents, and fellows receive their training and education. They are equipped with advanced medical technology and resources to provide specialized and tertiary care services. University hospitals also conduct research and clinical trials to advance medical knowledge and practices. Additionally, they often treat complex and rare cases and provide a wide range of medical services to the community.

Bacterial meningitis is a serious infection that causes the membranes (meninges) surrounding the brain and spinal cord to become inflamed. It's caused by various types of bacteria, such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b.

The infection can develop quickly, over a few hours or days, and is considered a medical emergency. Symptoms may include sudden high fever, severe headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light. In some cases, a rash may also be present.

Bacterial meningitis can lead to serious complications such as brain damage, hearing loss, learning disabilities, and even death if not treated promptly with appropriate antibiotics and supportive care. It is important to seek immediate medical attention if you suspect bacterial meningitis. Vaccines are available to prevent certain types of bacterial meningitis.

A cephalosporinase is an enzyme that can break down and inactivate cephalosporins, a group of antibiotics commonly used to treat various bacterial infections. Bacteria that produce this enzyme are referred to as "cephalosporin-resistant" or "cephalosporinase-producing" organisms. The production of cephalosporinases by bacteria can lead to treatment failures and make infections more difficult to manage.

Cephalosporins are broad-spectrum antibiotics, which means they can be effective against a wide range of bacterial species. However, some bacteria have developed resistance mechanisms, such as the production of cephalosporinases, to counteract their effects. These enzymes hydrolyze the beta-lactam ring in cephalosporins, rendering them ineffective.

There are different classes of cephalosporinases (e.g., Ambler classes A, C, and D), each with distinct characteristics and substrate profiles. Some cephalosporinases can hydrolyze a broader range of cephalosporins than others, leading to varying degrees of resistance.

To overcome cephalosporinase-mediated resistance, alternative antibiotics or combinations of antibiotics may be used. Additionally, the development of new cephalosporins with improved stability against these enzymes is an ongoing area of research in the field of antimicrobial drug discovery.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

Sepsis is a life-threatening condition that arises when the body's response to an infection injures its own tissues and organs. It is characterized by a whole-body inflammatory state (systemic inflammation) that can lead to blood clotting issues, tissue damage, and multiple organ failure.

Sepsis happens when an infection you already have triggers a chain reaction throughout your body. Infections that lead to sepsis most often start in the lungs, urinary tract, skin, or gastrointestinal tract.

Sepsis is a medical emergency. If you suspect sepsis, seek immediate medical attention. Early recognition and treatment of sepsis are crucial to improve outcomes. Treatment usually involves antibiotics, intravenous fluids, and may require oxygen, medication to raise blood pressure, and corticosteroids. In severe cases, surgery may be required to clear the infection.

Anaerobiosis is a state in which an organism or a portion of an organism is able to live and grow in the absence of molecular oxygen (O2). In biological contexts, "anaerobe" refers to any organism that does not require oxygen for growth, and "aerobe" refers to an organism that does require oxygen for growth.

There are two types of anaerobes: obligate anaerobes, which cannot tolerate the presence of oxygen and will die if exposed to it; and facultative anaerobes, which can grow with or without oxygen but prefer to grow in its absence. Some organisms are able to switch between aerobic and anaerobic metabolism depending on the availability of oxygen, a process known as "facultative anaerobiosis."

Anaerobic respiration is a type of metabolic process that occurs in the absence of molecular oxygen. In this process, organisms use alternative electron acceptors other than oxygen to generate energy through the transfer of electrons during cellular respiration. Examples of alternative electron acceptors include nitrate, sulfate, and carbon dioxide.

Anaerobic metabolism is less efficient than aerobic metabolism in terms of energy production, but it allows organisms to survive in environments where oxygen is not available or is toxic. Anaerobic bacteria are important decomposers in many ecosystems, breaking down organic matter and releasing nutrients back into the environment. In the human body, anaerobic bacteria can cause infections and other health problems if they proliferate in areas with low oxygen levels, such as the mouth, intestines, or deep tissue wounds.

Butylene glycols are a type of organic compounds that belong to the class of diols, which are chemical compounds containing two hydroxyl groups. Specifically, butylene glycols are composed of a four-carbon chain with two hydroxyl groups located on adjacent carbon atoms.

There are two isomeric forms of butylene glycol: 1,2-butanediol and 1,3-butanediol.

* 1,2-Butanediol (also known as 1,2-butylene glycol) has the hydroxyl groups on the first and second carbon atoms of the chain. It is a colorless, viscous liquid that is used as a solvent, humectant, and antifreeze in various industrial and cosmetic applications.
* 1,3-Butanediol (also known as 1,3-butylene glycol) has the hydroxyl groups on the first and third carbon atoms of the chain. It is also a colorless, viscous liquid that is used as a solvent, humectant, and antifreeze in various industrial and cosmetic applications.

Butylene glycols are generally considered to be safe for use in cosmetics and other consumer products, although they may cause skin irritation or allergic reactions in some individuals. They are also used as intermediates in the synthesis of other chemicals, such as polyesters and polyurethanes.

A lung is a pair of spongy, elastic organs in the chest that work together to enable breathing. They are responsible for taking in oxygen and expelling carbon dioxide through the process of respiration. The left lung has two lobes, while the right lung has three lobes. The lungs are protected by the ribcage and are covered by a double-layered membrane called the pleura. The trachea divides into two bronchi, which further divide into smaller bronchioles, leading to millions of tiny air sacs called alveoli, where the exchange of gases occurs.

Blood bactericidal activity refers to the ability of an individual's blood to kill or inhibit the growth of bacteria. This is an important aspect of the body's immune system, as it helps to prevent infection and maintain overall health. The bactericidal activity of blood can be influenced by various factors, including the presence of antibodies, white blood cells (such as neutrophils), and complement proteins.

In medical terms, the term "bactericidal" specifically refers to an agent or substance that is capable of killing bacteria. Therefore, when we talk about blood bactericidal activity, we are referring to the collective ability of various components in the blood to kill or inhibit the growth of bacteria. This is often measured in laboratory tests as a way to assess a person's immune function and their susceptibility to infection.

It's worth noting that not all substances in the blood are bactericidal; some may simply inhibit the growth of bacteria without killing them. These substances are referred to as bacteriostatic. Both bactericidal and bacteriostatic agents play important roles in maintaining the body's defense against infection.

Amikacin is a type of antibiotic known as an aminoglycoside, which is used to treat various bacterial infections. It works by binding to the 30S subunit of the bacterial ribosome, inhibiting protein synthesis and ultimately leading to bacterial cell death. Amikacin is often used to treat serious infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae. It may be given intravenously or intramuscularly, depending on the severity and location of the infection. As with all antibiotics, amikacin should be used judiciously to prevent the development of antibiotic resistance.

Biofilms are defined as complex communities of microorganisms, such as bacteria and fungi, that adhere to surfaces and are enclosed in a matrix made up of extracellular polymeric substances (EPS). The EPS matrix is composed of polysaccharides, proteins, DNA, and other molecules that provide structural support and protection to the microorganisms within.

Biofilms can form on both living and non-living surfaces, including medical devices, implants, and biological tissues. They are resistant to antibiotics, disinfectants, and host immune responses, making them difficult to eradicate and a significant cause of persistent infections. Biofilms have been implicated in a wide range of medical conditions, including chronic wounds, urinary tract infections, middle ear infections, and device-related infections.

The formation of biofilms typically involves several stages, including initial attachment, microcolony formation, maturation, and dispersion. Understanding the mechanisms underlying biofilm formation and development is crucial for developing effective strategies to prevent and treat biofilm-associated infections.

Endophthalmitis is a serious inflammatory eye condition that occurs when an infection develops inside the eyeball, specifically within the vitreous humor (the clear, gel-like substance that fills the space between the lens and the retina). This condition can be caused by bacteria, fungi, or other microorganisms that enter the eye through various means, such as trauma, surgery, or spread from another infected part of the body.

Endophthalmitis is often characterized by symptoms like sudden onset of pain, redness, decreased vision, and increased sensitivity to light (photophobia). If left untreated, it can lead to severe complications, including blindness. Treatment typically involves administering antibiotics or antifungal medications, either systemically or directly into the eye, and sometimes even requiring surgical intervention to remove infected tissues and relieve intraocular pressure.

An abscess is a localized collection of pus caused by an infection. It is typically characterized by inflammation, redness, warmth, pain, and swelling in the affected area. Abscesses can form in various parts of the body, including the skin, teeth, lungs, brain, and abdominal organs. They are usually treated with antibiotics to eliminate the infection and may require drainage if they are large or located in a critical area. If left untreated, an abscess can lead to serious complications such as sepsis or organ failure.

Streptolysins are exotoxins produced by certain strains of Streptococcus bacteria, primarily Group A Streptococcus (GAS). These toxins are classified into two types: streptolysin O (SLO) and streptolysin S (SLS).

1. Streptolysin O (SLO): It is a protein exotoxin that exhibits oxygen-labile hemolytic activity, meaning it can lyse or destroy red blood cells in the presence of oxygen. SLO is capable of entering host cells and causing various cellular damages, including inhibition of phagocytosis, modulation of immune responses, and induction of apoptosis (programmed cell death).

2. Streptolysin S (SLS): It is a non-protein, oxygen-stable hemolysin that can also lyse red blood cells but does so independently of oxygen presence. SLS is more heat-resistant than SLO and has a stronger ability to penetrate host cell membranes.

Both streptolysins contribute to the virulence of Streptococcus pyogenes, which can cause various clinical infections such as pharyngitis (strep throat), impetigo, scarlet fever, and invasive diseases like necrotizing fasciitis and toxic shock syndrome.

The detection of streptolysin O antibodies (ASO titer) is often used as a diagnostic marker for past or recent GAS infections, particularly in cases of rheumatic fever, where elevated ASO titers indicate ongoing or previous streptococcal infection.

Naphthyridines are a class of heterocyclic organic compounds that contain a naphthyridine core structure, which is a polycyclic aromatic hydrocarbon made up of two benzene rings fused to a tetrahydropyridine ring. They have a variety of pharmacological activities and are used in the development of various therapeutic agents, including antibiotics, antivirals, and anticancer drugs.

In medical terms, naphthyridines do not have a specific clinical definition or application, but they are rather a chemical class that is utilized in the design and synthesis of drugs with potential therapeutic benefits. The unique structure and properties of naphthyridines make them attractive candidates for drug development, particularly in areas where new treatments are needed to overcome drug resistance or improve efficacy.

It's worth noting that while naphthyridines have shown promise in preclinical studies, further research is needed to fully understand their safety and effectiveness in humans before they can be approved as therapeutic agents.

"Serratia" is a genus of Gram-negative, facultatively anaerobic, motile bacilli that are commonly found in the environment, such as in water and soil. Some species, particularly "Serratia marcescens," can cause healthcare-associated infections, including pneumonia, urinary tract infections, wound infections, and bloodstream infections. These infections often occur in patients with compromised immune systems or who have been hospitalized for extended periods of time. Serratia species are resistant to multiple antibiotics, which can make treatment challenging.

Ribitol is a sugar alcohol, specifically a pentitol, that is a reduced form of the pentose sugar ribose. It is found in some fruits and vegetables, and it can also be produced synthetically. In biochemistry, ribitol plays a role as a component of certain coenzymes and as a constituent of the structural polysaccharides in the cell walls of some bacteria. It has been used in research and medical applications, such as in the study of bacterial metabolism and in the development of potential drugs.

Bacterial antigens are substances found on the surface or produced by bacteria that can stimulate an immune response in a host organism. These antigens can be proteins, polysaccharides, teichoic acids, lipopolysaccharides, or other molecules that are recognized as foreign by the host's immune system.

When a bacterial antigen is encountered by the host's immune system, it triggers a series of responses aimed at eliminating the bacteria and preventing infection. The host's immune system recognizes the antigen as foreign through the use of specialized receptors called pattern recognition receptors (PRRs), which are found on various immune cells such as macrophages, dendritic cells, and neutrophils.

Once a bacterial antigen is recognized by the host's immune system, it can stimulate both the innate and adaptive immune responses. The innate immune response involves the activation of inflammatory pathways, the recruitment of immune cells to the site of infection, and the production of antimicrobial peptides.

The adaptive immune response, on the other hand, involves the activation of T cells and B cells, which are specific to the bacterial antigen. These cells can recognize and remember the antigen, allowing for a more rapid and effective response upon subsequent exposures.

Bacterial antigens are important in the development of vaccines, as they can be used to stimulate an immune response without causing disease. By identifying specific bacterial antigens that are associated with virulence or pathogenicity, researchers can develop vaccines that target these antigens and provide protection against infection.

Pneumococcal meningitis is a specific type of bacterial meningitis, which is an inflammation of the membranes covering the brain and spinal cord (meninges). It is caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium is commonly found in the upper respiratory tract and middle ear fluid of healthy individuals. However, under certain circumstances, it can invade the bloodstream and reach the meninges, leading to meningitis.

Pneumococcal meningitis is a serious and potentially life-threatening condition that requires immediate medical attention. Symptoms may include sudden onset of fever, severe headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light (photophobia). In some cases, it can also lead to complications such as hearing loss, brain damage, or even death if not treated promptly and effectively.

Treatment typically involves the use of antibiotics that are effective against pneumococcus, such as ceftriaxone or vancomycin. In some cases, corticosteroids may also be used to reduce inflammation and prevent complications. Prevention measures include vaccination with the pneumococcal conjugate vaccine (PCV13) or the pneumococcal polysaccharide vaccine (PPSV23), which can help protect against pneumococcal infections, including meningitis.

Bacteriophages, often simply called phages, are viruses that infect and replicate within bacteria. They consist of a protein coat, called the capsid, that encases the genetic material, which can be either DNA or RNA. Bacteriophages are highly specific, meaning they only infect certain types of bacteria, and they reproduce by hijacking the bacterial cell's machinery to produce more viruses.

Once a phage infects a bacterium, it can either replicate its genetic material and create new phages (lytic cycle), or integrate its genetic material into the bacterial chromosome and replicate along with the bacterium (lysogenic cycle). In the lytic cycle, the newly formed phages are released by lysing, or breaking open, the bacterial cell.

Bacteriophages play a crucial role in shaping microbial communities and have been studied as potential alternatives to antibiotics for treating bacterial infections.

PII nitrogen regulatory proteins are a type of signal transduction protein involved in the regulation of nitrogen metabolism in bacteria and archaea. They are named "PII" because they contain two identical subunits, each with a molecular weight of approximately 12 kilodaltons. These proteins play a crucial role in sensing and responding to changes in the energy status and nitrogen availability within the cell.

The PII protein is composed of three domains: the T-domain, which binds ATP and ADP; the N-domain, which binds 2-oxoglutarate (an indicator of carbon and nitrogen status); and the B-domain, which is involved in signal transduction. The PII protein can exist in different conformational states depending on whether it is bound to ATP or ADP, and this affects its ability to interact with downstream effectors.

One of the primary functions of PII proteins is to regulate the activity of glutamine synthetase (GS), an enzyme that catalyzes the conversion of glutamate to glutamine. When nitrogen is abundant, PII proteins bind to GS and stimulate its activity, promoting the assimilation of ammonia into organic compounds. Conversely, when nitrogen is scarce, PII proteins dissociate from GS, allowing it to be inhibited by other regulatory proteins.

PII proteins can also interact with other enzymes and regulators involved in nitrogen metabolism, such as nitrogenase, uridylyltransferase/uridylyl-removing enzyme (UT/UR), and transcriptional regulators. Through these interactions, PII proteins help to coordinate the cell's response to changes in nitrogen availability and energy status, ensuring that resources are allocated efficiently and effectively.

Blood is the fluid that circulates in the body of living organisms, carrying oxygen and nutrients to the cells and removing carbon dioxide and other waste products. It is composed of red and white blood cells suspended in a liquid called plasma. The main function of blood is to transport oxygen from the lungs to the body's tissues and carbon dioxide from the tissues to the lungs. It also transports nutrients, hormones, and other substances to the cells and removes waste products from them. Additionally, blood plays a crucial role in the body's immune system by helping to fight infection and disease.

Polymyxin B is an antibiotic derived from the bacterium Paenibacillus polymyxa. It belongs to the class of polypeptide antibiotics and has a cyclic structure with a hydrophobic and a hydrophilic region, which allows it to interact with and disrupt the bacterial cell membrane. Polymyxin B is primarily active against gram-negative bacteria, including many multidrug-resistant strains. It is used clinically to treat serious infections caused by these organisms, such as sepsis, pneumonia, and urinary tract infections. However, its use is limited due to potential nephrotoxicity and neurotoxicity.

Wikimedia Commons has media related to Klebsiella pneumoniae. Scholia has a topic profile for Klebsiella pneumoniae. Virtual ... Klebsiella Infection (emedicine.com) Klebsiella Genome Projects from Genomes OnLine Database Klebsiella pneumoniae-Associated ... Klebsiella Infections at eMedicine Li B, Zhao Y, Liu C, Chen Z, Zhou D (2014). "Molecular pathogenesis of Klebsiella pneumoniae ... MarketVIEW: Klebsiella pneumoniae vaccines. https://www.vaczine-analytics.com/products-marketviewVAMV087_klebsiella_pneumoniae_ ...
"Klebsiella pneumoniae". www.jic.ac.uk. Archived from the original on 2007-10-17. Iwo Watanabe, "Biological Nitrogen Fixation ... Nif regulon (Klebsiella pneumoniae) Spaink, Herman P (1998). The Rhizobiaceae: Molecular Biology of Model Plant-Associated ... Examples of nif gene structure and regulation in different diazotrophs include: Klebsiella pneumoniae-a free-living anaerobic ...
ISBN 978-0-8385-8529-0. "Klebsiella pneumoniae in Healthcare Settings". Centers for Disease Control and Prevention. 19 February ... Klebsiella pneumoniae, Legionella pneumophila, Neisseria gonorrhoeae, Neisseria meningitidis, Staphylococcus aureus, ... Belland R, Ouellette S, Gieffers J, Byrne G (2004). "Chlamydia pneumoniae and atherosclerosis". Cell Microbiol. 6 (2): 117-27. ... Streptococcus pneumoniae and Vibrio cholerae.[citation needed] Human microbiome project List of antibiotics Pathogenic viruses ...
In Klebsiella pneumoniae the cystathionine β-synthase is encoded by mtcB, while the γ-lyase is encoded by mtcC. Humans are ... Seiflein, T. A.; Lawrence, J. G. (2006). "Two Transsulfurylation Pathways in Klebsiella pneumoniae". Journal of Bacteriology. ...
"Klebsiella pneumoniae in Healthcare Settings - HAI". CDC. 17 May 2019. Retrieved 6 April 2022. Increasingly, Klebsiella ... For instance, some Klebsiella pneumoniae strains are carbapenem resistant. Various carbapenemases genes (blaOXA-48, blaKPC and ... These are Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. However, Proteus mirabilis is now considered a part ... have been identified in carbapenem resistant Enterobacteriaceae including Escherichia coli and Klebsiella pneumoniae. "List of ...
Klebsiella pneumoniae, Proteus spp. ), and Pseudomonas aeruginosa. Exposure to higher doses of radiation is associated with ... Levofloxacin has expanded Gram-positive coverage (penicillin-sensitive and penicillin-resistant S. pneumoniae) and expanded ... including Staphylococcus aureus and Streptococcus pneumoniae) and some atypical pathogens. ...
Klebsiella pneumoniae, Pseudomonas aeruginosa, and Enterobacter spp. Urinary incontinence* is leakage of urine, usually due to ...
HS-1 also has antimicrobial effects on some bacterial species, i.e. Bacillus subtilis, Klebsiella pneumoniae and Pseudomonas ...
Klebsiella pneumoniae is the most common Klebsiella species found in humans, the gastrointestinal tracts of animals, in sewage ... Bruce SK, Schick DG, Tanaka L, Jimenez EM, Montgomerie JZ (June 1981). "Selective medium for isolation of Klebsiella pneumoniae ... Enterobacter are distinguished from Klebsiella because of their differences in motility. Klebsiella are non-motile, Gram- ... The media used for selecting for Klebsiella species in a mixed sample is an agar including ornithine, raffinose, and Koser ...
Klebsiella pneumoniae was identified as one of six leading pathogens for disease associated with resistance in 2019 and that ... NDM-1 was first detected in a Klebsiella pneumoniae isolate from a Swedish patient of Indian origin in 2008. It was later ... Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria are a group of emerging highly drug-resistant Gram-negative ... Klebsiella pneumoniae includes numerous mechanisms for antibiotic resistance, many of which are located on highly mobile ...
In plant systems, Klebsiella can be found in a variety of plant hosts. K. pneumoniae and K. oxytoca are able to fix atmospheric ... However, currently, no Klebsiella vaccine has been licensed for use in the US. K. pneumoniae is the most common cause of ... The majority of human Klebsiella infections are caused by K. pneumoniae, followed by K. oxytoca. Infections are more common in ... Klebsiella is named after German-Swiss microbiologist Edwin Klebs (1834-1913). Carl Friedlander described Klebsiella bacillus ...
In very rare cases, cerebritis may occur as a result of a Klebsiella pneumoniae infection. One other reason to develop ... "Cerebritis: An unusual complication of Klebsiella pneumoniae". Archived from the original on 2011-01-27. Retrieved 2010-04-20 ...
The body produces antibodies that attack Klebsiella pneumoniae. Enzymes made by the bacterium resemble human proteins, ... has implicated overgrowth of the bacterium Klebsiella pneumoniae in the symptoms of ankylosing spondylitis. ...
"Weak biofilm formation among carbapenem-resistant Klebsiella pneumoniae". Diagnostic Microbiology and Infectious Disease. 95 (4 ...
Venkatachalam, I; Teo J; Balm MN; Fisher DA; Jureen R; Lin RT (August 2012). "Klebsiella pneumoniae Carbapenemase-producing ...
"Klebsiella pneumoniae strain KPS77 plasmid pKPS77, complete sequence". NCBI. Retrieved 10 September 2014. Pritchard, Leighton; ...
The class A Klebsiella pneumoniae carbapenemase (KPC) is currently the most common carbapenemase, which was first detected in ... NDM-1 was first detected in 2008 in a culture plate of Klebsiella pneumoniae isolated from a Swedish patient of Indian origin. ... The most common bacteria that make this enzyme are gram-negative such as Escherichia coli and Klebsiella pneumoniae, but the ... The infection was identified as a carbapenem-resistant Klebsiella pneumoniae strain bearing the novel gene blaNDM-1. The ...
Song H, Li G, Ye J, Wan F, Qian Y (2004). "Immunomodulating effects of cefodizime on Klebsiella pneumoniae-stimulated ... in neutrophils stimulated by Klebsiella pneumoniae infection which then affected the production of cytokines in the stimulated ... pneumoniae and S. pyogenes. Cefodizime was shown to be ineffective in vitro against Enterobacter spp., Pseudomonas aeruginosa, ... pneumoniae, Morganella morganii, Proteus mirabilis, P. vulgaris, Shigella sonnei, Yersinia enterocolitica, Salmonella, ...
Klebsiella oxytoca, Klebsiella pneumoniae, vancomycin-susceptible Enterococcus faecalis, methicillin-resistant Staphylococcus ... Escherichia coli: 0.015 μg/mL - 4 μg/mL[citation needed] Klebsiella pneumoniae: 0.06 μg/mL - 16 μg/mL[citation needed] ... Klebsiella pneumoniae, and Bacteroides fragilis. Tigecycline is indicated for treatment of complicated intra-abdominal ... penicillin susceptible Streptococcus pneumoniae, Haemophilus influenzae that does not produce Beta-lactamase and Legionella ...
Klebsiella pneumoniae strain AIMST Nalme7 16S ribosomal RNA gene, partial sequence. NCBI. Klebsiella pneumoniae strain AIMST ... Klebsiella Klebsiella oxytoca strain AIMST Nae2 (N. ampullaria; Selangor, Malaysia; leaf tissue) Klebsiella pneumoniae strain ... Klebsiella pneumoniae strain AIMST Ngse5 (N. gracilis; Selangor, Malaysia; leaf tissue) Kluyvera Kluyvera ascorbata strain ... Klebsiella oxytoca strain AIMST Nae2 16S ribosomal RNA gene, partial sequence. NCBI. ...
"The sodium ion translocating oxaloacetate decarboxylase of Klebsiella pneumoniae. Sequence of the integral membrane-bound ... ions upon decarboxylation of oxaloacetate by the membrane-bound and Na+-activated oxaloacetate decarboxylase from Klebsiella ...
Originally described from New Delhi in 2009, this gene is now widespread in Escherichia coli and Klebsiella pneumoniae from ... As of February 2009[update], the class A Klebsiella pneumoniae carbapenemase (KPC) globally has been the most common ... Nordmann P, Cuzon G, Naas T (April 2009). "The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria". The ... pneumoniae, Klebsiella oxytoca, P. mirabilis, and Citrobacter freundii. Although the inhibitor-resistant TEM variants are ...
aeruginosa and putida), Bacillus spp., Klebsiella pneumoniae, Enterococcus species, Staphylococcus aureus, and Enterobacter ...
Klebsiella pneumoniae, or Klebsiella oxytoca. Some exclude ertapenem resistance from the definition. Hospitals are primary ... In Klebsiella pneumoniae, the lack of either OmpK35 or OmpK36 leads to carbapenem resistance, but with the lack of both ... Klebsiella pneumoniae has been associated with the lack of outer membrane porin proteins, OmpK35 and OmpK36. The loss of OmpK36 ... Calfee, DP; Patel, G; Huprikar, S; Factor, SH; Jenkins, SG (2008). "Outcomes of carbapenem-resistant Klebsiella pneumoniae ...
Klebsiella pneumoniae plasmid) which promote conjugative-pilus-dependent biofilm formation. Transformation commonly occurs ... "Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumoniae". Pathogens. 3 (3): 743-758. doi:10.3390/ ... Competent S. pneumoniae in a biofilm have the survival advantage that they can more easily take up transforming DNA from nearby ... Streptococcus pneumoniae is the main cause of community-acquired pneumonia and meningitis in children and the elderly, and of ...
US US5876982A, Paul, Francois; Perry, David & Monsan, Pierre, "Strain of Klebsiella pneumoniae, subsp. pneumoniae, and a ...
F. alba grows with Klebsiella pneumoniae upon a nutrient agar. In the study done by Worley et al (1979), Fonticula alba was ... However, compared to K.pneumoniae, the sorocarps that grew with E. coli were smaller in size. F. alba grows at an optimal ...
Wray JW, Abeles RH (1995). "The methionine salvage pathway in Klebsiella pneumoniae and rat liver. Identification and ... 13C and 15N NMR assignments for a carbon monoxide generating metalloenzyme from Klebsiella pneumoniae". J. Biomol. NMR. 14 (3 ... S-methylthioadenosine to methionine in Klebsiella pneumoniae". J. Biol. Chem. 263 (20): 9598-606. PMID 2838472. Dai Y, Wensink ... "Modeling and experiment yields the structure of acireductone dioxygenase from Klebsiella pneumoniae". Nat. Struct. Biol. 9 (12 ...
Wray JW, Abeles RH (February 1995). "The methionine salvage pathway in Klebsiella pneumoniae and rat liver. Identification and ... enzyme involved in oxidative carbon-carbon bond cleavage reactions in the methionine salvage pathway of Klebsiella pneumoniae ...
Wray JW, Abeles RH (1995). "The methionine salvage pathway in Klebsiella pneumoniae and rat liver. Identification and ... S-methylthioadenosine to methionine in Klebsiella pneumoniae". J. Biol. Chem. 263 (20): 9598-606. doi:10.1016/S0021-9258(19) ...
Detection of the blaKPC Gene Encoding Klebsiella pneumoniae Carbapenemase by Real-Time PCR. 12.5.4.1−12.5.4.10. ... Multiplex Real-Time PCR Detection of Klebsiella pneumoniae Carbapenemase (KPC) and New Delhi metallo-β-lactamase (NDM-1) genes ... KPC- and NDM-negative control - K. pneumoniae ATCC strain BAA-1706. *KPC-positive control - K. pneumoniae ATCC strain BAA-1705 ... pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 43:5046-54. ...
Wikimedia Commons has media related to Klebsiella pneumoniae. Scholia has a topic profile for Klebsiella pneumoniae. Virtual ... Klebsiella Infection (emedicine.com) Klebsiella Genome Projects from Genomes OnLine Database Klebsiella pneumoniae-Associated ... Klebsiella Infections at eMedicine Li B, Zhao Y, Liu C, Chen Z, Zhou D (2014). "Molecular pathogenesis of Klebsiella pneumoniae ... MarketVIEW: Klebsiella pneumoniae vaccines. https://www.vaczine-analytics.com/products-marketviewVAMV087_klebsiella_pneumoniae_ ...
Cytidine deaminase1,4-DIETHYLENE DIOXIDEZINC ION
Detection of Klebsiella pneumoniae carbapenemase (KPC) production in non-Klebsiella pneumoniae Enterobacteriaceae isolates by ... High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt ... Prévalence élevée de la résistance de Klebsiella pneumoniae médiée par les carbapénèmases dans des isolats de K. pneumoniae en ... An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek ...
The certificate of origin for that lot of Klebsiella pneumoniae subsp. pneumoniae (Schroeter) Trevisan (4211) is not currently ... To download a certificate of analysis for Klebsiella pneumoniae subsp. pneumoniae (Schroeter) Trevisan (4211), enter the lot ... The certificate of analysis for that lot of Klebsiella pneumoniae subsp. pneumoniae (Schroeter) Trevisan (4211) is not ... To download a certificate of origin for Klebsiella pneumoniae subsp. pneumoniae (Schroeter) Trevisan (4211), enter the lot ...
Complete Genome Sequence of Klebsiella pneumoniae Strain ATCC 43816 KPPR1, a Rifampin-Resistant Mutant Commonly Used in Animal ... Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Klebsiella/Raoultella group; Klebsiella. ...
Klebsiella pneumoniae). Find diseases associated with this biological target and compounds tested against it in bioassay ...
Discover the impact of the mucoid phenotype on antibiotic resistance in Klebsiella pneumoniae. Explore the prevalence, ... Klebsiella pneumoniae is a gram negative bacteria and an opportunistic pathogen. In humans K. pneumoniae is an important ... Klebsiella pneumoniae is an opportunistic pathogen of medical importance and the capsule and mucoid phenotype in this organism ... 2011) Klebsiella pneumoniae Outer Membrane Porins OmpK35 and OmpK36 Play Roles in Both Antimicrobial Resistance and Virulence. ...
Effective cOmbination of Phages and Antibiotics for improved TheRApy of KLEbsiella pneumoniae. 06/2023-05/2026 ... In addition, available Klebsiella bacteriophages from the consortium will be sequenced to provide detailed information on the ... The aim of the project is to improve the control of multidrug resistant K. pneumoniae infections by a combined use of ... The project is concerned with the characterization of a K. pneumoniae strain collection corresponding to a One Helath approach ...
For vaccination of healthy cattle 22 months or older against mastitis caused by Klebsiella pneumoniae. Dosage: 2 ml subcut. ... For vaccination of healthy cattle 22 months or older against mastitis caused by Klebsiella pneumoniae. ... For vaccination of healthy cattle 22 months or older against mastitis caused by Klebsiella pneumoniae. ... Klebsiella mastitis vaccine with Siderophore Receptor and Porin technology helps keep cows healthy and productive ...
Antimicrobial activity against Klebsiella pneumoniae MTCC 109 by paper disk diffusion method. ...
Mathematical modeling; Klebsiella pneumoniae; extended spectrum beta lactamases (ESBL) Cite This Article. Bagkur, C., Guler, E ... Klebsiella pneumoniae is one of the significant microorganisms causing major public health problems by acquiring resistance to ... Near Future Perspective of ESBL-Producing Klebsiella pneumoniae Strains Using Mathematical Modeling. Cemile Bagkur1,*, Emrah ... Near Future Perspective of ESBL-Producing Klebsiella pneumoniae Strains Using Mathematical Modeling. CMES-Computer Modeling in ...
Klebsiella pneumoniae (K. pneumoniae) causes a wide range of infections, including pneumonia, urinary tract infections, ... Klebsiella pneumoniae is responsible for severe infections and stands out for its high resistance to antibiotics. ... PHAXIAMs anti-Klebsiella pneumoniae phages to enter pre-clinical development to assess their efficacy in lung, blood and ... PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target. ...
This study aimed to investigate the prevalence of ciprofloxacin-resistant K pneumoniae in burns patients and to understand the ... pneumoniae is caused by mutation of porin-related proteins and efflux pumps. ... ABSTRACT The main mechanism of quinolone resistance in Klebsiella (K) ... The main mechanism of quinolone resistance in Klebsiella (K) pneumoniae is caused by mutation of porin-related proteins and ...
Tags: abstract, antibiotics, canada, carbapenem, drug resistance, escherichia coli, fatal case, klebsiella pneumoniae, ndm-1, ... New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada (Emerg Infect Dis., abstract, edited) [ ... New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Michael R. Mulvey, Jennifer M. Grant, ... Multidrug-resistant Klebsiella pneumoniae and Escherichia coli isolates harboring New Delhi metallo-β-lactamase (NDM-1) were ...
A Klebsiella ozaenae nitrilase converts the herbicide bromoxynil (3,5-dibromo-4 hydroxybenzo-nitrile) to 3,6-dibromo-4- ...
Capsule is an important virulence factor for Klebsiella pneumoniae and infections due to this pathogen have been associated ... In the present study, use of an Aeromonas punctata derived capsule depolymerase against K. pneumoniae, to reinstate the ... pneumoniae in vivo but it also increased its susceptibility to gentamicin at a lower concentration. Such a strategy would help ... pneumoniae B5055 and treated with gentamicin (1.5 mg/kg) and/or depolymerase (50 μg). G1, G2, G3, G4 represent Groups 1, 2, 3, ...
Klebsiella pneumoniae (K. pneumoniae) causes a wide range of infections, including pneumonia, urinary tract infections, ... Klebsiella pneumoniae is responsible for severe infections and stands out for its high resistance to antibiotics. ... PHAXIAMs anti-Klebsiella pneumoniae phages to enter pre-clinical development to assess their efficacy in lung, blood and ... PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target. ...
Species: Klebsiella pneumoniae. Download Options Full Lineage: Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales ...
... we introduced sublethal concentrations of Klebsiella pneumoniae into the lungs of rats via intranasal inoculation and followed ... with multiple doses of predatory bacteria over24 h. Predatory bacteria were able to reduce K. pneumoniae bacterial burden, on ... we introduced sublethal concentrations of Klebsiella pneumoniae into the lungs of rats via intranasal inoculation and followed ... with multiple doses of predatory bacteria over24 h. Predatory bacteria were able to reduce K. pneumoniae bacterial burden, on ...
ICU-acquired Carbapenem-non-susceptible Bacilli in Indonesia Focus on: Acinetobacter baumannii, Klebsiella pneumoniae and ... ICU-verworven Carbapenem-niet-gevoelige Bacillen in Indonesië Focus op: Acinetobacter baumannii, Klebsiella pneumoniae en ... We here describe the epidemiology of carbapenem-non-susceptible Acinetobacter baumannii (CNAB), Klebsiella pneumoniae (CNKP) ... antimicrobial resistance, carbapenem, A. baumannii, K. pneumoniae, P.aeruginosa, intensive care unit, Indonesia ...
Klebsiella pneumoniae carbapenemasa, principal carbapenemasa en enterobacterias KPC: Klebsiella pneumoniae carbapenemase, main ... David S, Reuter S, Harris SR, Glasner C, Feltwell T, Argimon S, et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae ... Gomez SA, Pasteran FG, Faccone D, Tijet N, Rapoport M, Lucero C, et al. Clonal dissemination of Klebsiella pneumoniae ST258 ... Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: ...
Klebsiella pneumoniae pneumonia. The radiographic patterns seen in Klebsiella pneumonia include patchy bronchopneumonia and ... Klebsiella pneumoniae pneumonia is typically associated with a lobar infiltrate in the posterior aspect of the right upper lung ... Radiological patterns and prognosis in elderly patients with acute Klebsiella pneumoniae pneumonia: A retrospective study. ... Streptococcus pneumoniae pneumonia. Streptococcus pneumoniae is the most frequent bacterial pathogen in patients with community ...
Percentage of invasive isolates of Klebsiella pneumoniae with combined resistance to fluoroquinolones, third-generation ... Multidrug-resistant Klebsiella pneumoniae Indicator full name: Percentage of invasive isolates of Klebsiella pneumoniae with ... Percentage of invasive isolates of Klebsiella pneumoniae with combined resistance to fluoroquinolones, third-generation ...
Klebsiella Infections Klebsiella Pneumoniae Phylogeny Sequence Analysis, DNA ... "Phylogenetic Analysis of Klebsiella pneumoniae from Hospitalized Children, Pakistan" 23, no. 11 (2017). Ejaz, Hasan et al. " ... "Phylogenetic Analysis of Klebsiella pneumoniae from Hospitalized Children, Pakistan" vol. 23, no. 11, 2017. Export RIS Citation ... Ceftazidime/Avibactam Resistance in Carbapenemase-Producing Klebsiella pneumoniae Cite CITE. Title : Ceftazidime/Avibactam ...
Klebsiella pneumoniae. Escheríchia coli. Genoma humà. Enterobacteriàcies. Beta lactam antibiotics. Klebsiella pneumoniae. ... CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces ... pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance ...
Klebsiella pneumoniae. *Pseudomonas aeruginosa. *Serratia marcescens. Gram-negative meningitis is more common in infants than ...

No FAQ available that match "klebsiella pneumoniae"

No images available that match "klebsiella pneumoniae"